GO:0022402 | cell cycle process | 46.39% (77/166) | 3.6 | 0.0 | 0.0 |
GO:1903047 | mitotic cell cycle process | 36.14% (60/166) | 4.28 | 0.0 | 0.0 |
GO:0005874 | microtubule | 24.1% (40/166) | 4.41 | 0.0 | 0.0 |
GO:0099513 | polymeric cytoskeletal fiber | 25.3% (42/166) | 4.23 | 0.0 | 0.0 |
GO:0099081 | supramolecular polymer | 25.3% (42/166) | 4.15 | 0.0 | 0.0 |
GO:0099512 | supramolecular fiber | 25.3% (42/166) | 4.15 | 0.0 | 0.0 |
GO:0006996 | organelle organization | 44.58% (74/166) | 2.52 | 0.0 | 0.0 |
GO:0007017 | microtubule-based process | 25.3% (42/166) | 3.66 | 0.0 | 0.0 |
GO:0008017 | microtubule binding | 17.47% (29/166) | 4.58 | 0.0 | 0.0 |
GO:0099080 | supramolecular complex | 25.9% (43/166) | 3.3 | 0.0 | 0.0 |
GO:0051726 | regulation of cell cycle | 25.9% (43/166) | 3.2 | 0.0 | 0.0 |
GO:0015631 | tubulin binding | 17.47% (29/166) | 4.26 | 0.0 | 0.0 |
GO:0000226 | microtubule cytoskeleton organization | 19.88% (33/166) | 3.77 | 0.0 | 0.0 |
GO:0008574 | plus-end-directed microtubule motor activity | 9.04% (15/166) | 6.7 | 0.0 | 0.0 |
GO:0003777 | microtubule motor activity | 10.84% (18/166) | 5.88 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 46.39% (77/166) | 1.91 | 0.0 | 0.0 |
GO:0007051 | spindle organization | 14.46% (24/166) | 4.7 | 0.0 | 0.0 |
GO:0007010 | cytoskeleton organization | 22.29% (37/166) | 3.37 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 52.41% (87/166) | 1.68 | 0.0 | 0.0 |
GO:0003774 | cytoskeletal motor activity | 11.45% (19/166) | 5.54 | 0.0 | 0.0 |
GO:0010564 | regulation of cell cycle process | 21.08% (35/166) | 3.47 | 0.0 | 0.0 |
GO:0008092 | cytoskeletal protein binding | 20.48% (34/166) | 3.47 | 0.0 | 0.0 |
GO:0051276 | chromosome organization | 18.07% (30/166) | 3.81 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 53.01% (88/166) | 1.61 | 0.0 | 0.0 |
GO:0005871 | kinesin complex | 9.64% (16/166) | 6.07 | 0.0 | 0.0 |
GO:0006974 | cellular response to DNA damage stimulus | 22.29% (37/166) | 3.23 | 0.0 | 0.0 |
GO:1903046 | meiotic cell cycle process | 19.28% (32/166) | 3.55 | 0.0 | 0.0 |
GO:0007052 | mitotic spindle organization | 11.45% (19/166) | 5.15 | 0.0 | 0.0 |
GO:0005875 | microtubule associated complex | 10.84% (18/166) | 5.25 | 0.0 | 0.0 |
GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 12.05% (20/166) | 4.84 | 0.0 | 0.0 |
GO:0005815 | microtubule organizing center | 16.27% (27/166) | 3.78 | 0.0 | 0.0 |
GO:0009524 | phragmoplast | 13.86% (23/166) | 4.24 | 0.0 | 0.0 |
GO:0070925 | organelle assembly | 16.87% (28/166) | 3.62 | 0.0 | 0.0 |
GO:0005813 | centrosome | 13.86% (23/166) | 4.13 | 0.0 | 0.0 |
GO:0022607 | cellular component assembly | 30.72% (51/166) | 2.28 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 35.54% (59/166) | 2.01 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 35.54% (59/166) | 2.01 | 0.0 | 0.0 |
GO:0090329 | regulation of DNA-templated DNA replication | 10.24% (17/166) | 5.06 | 0.0 | 0.0 |
GO:0051225 | spindle assembly | 10.84% (18/166) | 4.81 | 0.0 | 0.0 |
GO:0140657 | ATP-dependent activity | 19.28% (32/166) | 3.13 | 0.0 | 0.0 |
GO:0007018 | microtubule-based movement | 12.05% (20/166) | 4.28 | 0.0 | 0.0 |
GO:0010948 | negative regulation of cell cycle process | 12.65% (21/166) | 4.11 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 20.48% (34/166) | 2.88 | 0.0 | 0.0 |
GO:0006275 | regulation of DNA replication | 10.24% (17/166) | 4.75 | 0.0 | 0.0 |
GO:0140694 | non-membrane-bounded organelle assembly | 13.25% (22/166) | 3.9 | 0.0 | 0.0 |
GO:0090307 | mitotic spindle assembly | 8.43% (14/166) | 5.26 | 0.0 | 0.0 |
GO:0045786 | negative regulation of cell cycle | 12.65% (21/166) | 3.89 | 0.0 | 0.0 |
GO:1901987 | regulation of cell cycle phase transition | 13.86% (23/166) | 3.64 | 0.0 | 0.0 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 9.64% (16/166) | 4.7 | 0.0 | 0.0 |
GO:0006310 | DNA recombination | 11.45% (19/166) | 4.12 | 0.0 | 0.0 |
GO:0033043 | regulation of organelle organization | 18.07% (30/166) | 2.93 | 0.0 | 0.0 |
GO:0022616 | DNA strand elongation | 6.02% (10/166) | 6.25 | 0.0 | 0.0 |
GO:0000075 | cell cycle checkpoint signaling | 9.64% (16/166) | 4.4 | 0.0 | 0.0 |
GO:0006281 | DNA repair | 15.06% (25/166) | 3.17 | 0.0 | 0.0 |
GO:0005694 | chromosome | 13.86% (23/166) | 3.25 | 0.0 | 0.0 |
GO:0005819 | spindle | 10.24% (17/166) | 3.98 | 0.0 | 0.0 |
GO:0044782 | cilium organization | 7.83% (13/166) | 4.8 | 0.0 | 0.0 |
GO:1901988 | negative regulation of cell cycle phase transition | 9.64% (16/166) | 4.1 | 0.0 | 0.0 |
GO:0000724 | double-strand break repair via homologous recombination | 8.43% (14/166) | 4.52 | 0.0 | 0.0 |
GO:0000725 | recombinational repair | 8.43% (14/166) | 4.5 | 0.0 | 0.0 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 10.84% (18/166) | 3.64 | 0.0 | 0.0 |
GO:0005881 | cytoplasmic microtubule | 8.43% (14/166) | 4.36 | 0.0 | 0.0 |
GO:0006271 | DNA strand elongation involved in DNA replication | 4.82% (8/166) | 6.49 | 0.0 | 0.0 |
GO:0051301 | cell division | 13.86% (23/166) | 3.0 | 0.0 | 0.0 |
GO:0051052 | regulation of DNA metabolic process | 12.65% (21/166) | 3.17 | 0.0 | 0.0 |
GO:0005515 | protein binding | 66.87% (111/166) | 0.82 | 0.0 | 0.0 |
GO:0000911 | cytokinesis by cell plate formation | 7.23% (12/166) | 4.7 | 0.0 | 0.0 |
GO:0006302 | double-strand break repair | 9.04% (15/166) | 3.89 | 0.0 | 0.0 |
GO:0140097 | catalytic activity, acting on DNA | 10.24% (17/166) | 3.48 | 0.0 | 0.0 |
GO:0005876 | spindle microtubule | 7.23% (12/166) | 4.45 | 0.0 | 0.0 |
GO:1902975 | mitotic DNA replication initiation | 3.61% (6/166) | 7.29 | 0.0 | 0.0 |
GO:0030174 | regulation of DNA-templated DNA replication initiation | 4.82% (8/166) | 5.97 | 0.0 | 0.0 |
GO:0009574 | preprophase band | 6.02% (10/166) | 5.05 | 0.0 | 0.0 |
GO:0000910 | cytokinesis | 9.04% (15/166) | 3.75 | 0.0 | 0.0 |
GO:0099111 | microtubule-based transport | 7.23% (12/166) | 4.41 | 0.0 | 0.0 |
GO:0060271 | cilium assembly | 6.63% (11/166) | 4.68 | 0.0 | 0.0 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 7.83% (13/166) | 4.1 | 0.0 | 0.0 |
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 6.63% (11/166) | 4.62 | 0.0 | 0.0 |
GO:0051128 | regulation of cellular component organization | 22.29% (37/166) | 1.94 | 0.0 | 0.0 |
GO:0042555 | MCM complex | 3.61% (6/166) | 7.14 | 0.0 | 0.0 |
GO:1902292 | cell cycle DNA replication initiation | 3.61% (6/166) | 7.14 | 0.0 | 0.0 |
GO:1902315 | nuclear cell cycle DNA replication initiation | 3.61% (6/166) | 7.14 | 0.0 | 0.0 |
GO:0055028 | cortical microtubule | 7.23% (12/166) | 4.32 | 0.0 | 0.0 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 7.23% (12/166) | 4.29 | 0.0 | 0.0 |
GO:0006260 | DNA replication | 7.83% (13/166) | 3.97 | 0.0 | 0.0 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 13.86% (23/166) | 2.63 | 0.0 | 0.0 |
GO:0006270 | DNA replication initiation | 4.22% (7/166) | 6.23 | 0.0 | 0.0 |
GO:0005880 | nuclear microtubule | 4.22% (7/166) | 6.23 | 0.0 | 0.0 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 9.04% (15/166) | 3.56 | 0.0 | 0.0 |
GO:0019887 | protein kinase regulator activity | 7.23% (12/166) | 4.16 | 0.0 | 0.0 |
GO:0010970 | transport along microtubule | 6.63% (11/166) | 4.43 | 0.0 | 0.0 |
GO:0045930 | negative regulation of mitotic cell cycle | 7.83% (13/166) | 3.92 | 0.0 | 0.0 |
GO:0007346 | regulation of mitotic cell cycle | 10.84% (18/166) | 3.08 | 0.0 | 0.0 |
GO:0019207 | kinase regulator activity | 7.23% (12/166) | 4.11 | 0.0 | 0.0 |
GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication | 3.01% (5/166) | 7.62 | 0.0 | 0.0 |
GO:0036388 | pre-replicative complex assembly | 3.01% (5/166) | 7.62 | 0.0 | 0.0 |
GO:1902299 | pre-replicative complex assembly involved in cell cycle DNA replication | 3.01% (5/166) | 7.62 | 0.0 | 0.0 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 7.23% (12/166) | 4.05 | 0.0 | 0.0 |
GO:0032875 | regulation of DNA endoreduplication | 4.82% (8/166) | 5.45 | 0.0 | 0.0 |
GO:0120031 | plasma membrane bounded cell projection assembly | 6.63% (11/166) | 4.31 | 0.0 | 0.0 |
GO:0098813 | nuclear chromosome segregation | 5.42% (9/166) | 4.98 | 0.0 | 0.0 |
GO:0051493 | regulation of cytoskeleton organization | 9.04% (15/166) | 3.43 | 0.0 | 0.0 |
GO:1902554 | serine/threonine protein kinase complex | 6.63% (11/166) | 4.25 | 0.0 | 0.0 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 6.63% (11/166) | 4.23 | 0.0 | 0.0 |
GO:0030031 | cell projection assembly | 6.63% (11/166) | 4.23 | 0.0 | 0.0 |
GO:0042073 | intraciliary transport | 4.22% (7/166) | 5.88 | 0.0 | 0.0 |
GO:0005656 | nuclear pre-replicative complex | 3.01% (5/166) | 7.39 | 0.0 | 0.0 |
GO:0036387 | pre-replicative complex | 3.01% (5/166) | 7.39 | 0.0 | 0.0 |
GO:0016939 | kinesin II complex | 3.01% (5/166) | 7.39 | 0.0 | 0.0 |
GO:0000280 | nuclear division | 7.23% (12/166) | 3.93 | 0.0 | 0.0 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 6.63% (11/166) | 4.18 | 0.0 | 0.0 |
GO:0030030 | cell projection organization | 9.64% (16/166) | 3.17 | 0.0 | 0.0 |
GO:0006261 | DNA-templated DNA replication | 6.02% (10/166) | 4.39 | 0.0 | 0.0 |
GO:0048285 | organelle fission | 7.83% (13/166) | 3.63 | 0.0 | 0.0 |
GO:0003682 | chromatin binding | 11.45% (19/166) | 2.77 | 0.0 | 0.0 |
GO:0071162 | CMG complex | 3.01% (5/166) | 7.2 | 0.0 | 0.0 |
GO:1902911 | protein kinase complex | 6.63% (11/166) | 4.06 | 0.0 | 0.0 |
GO:0120036 | plasma membrane bounded cell projection organization | 8.43% (14/166) | 3.4 | 0.0 | 0.0 |
GO:0007049 | cell cycle | 10.84% (18/166) | 2.85 | 0.0 | 0.0 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 5.42% (9/166) | 4.67 | 0.0 | 0.0 |
GO:1904029 | regulation of cyclin-dependent protein kinase activity | 5.42% (9/166) | 4.67 | 0.0 | 0.0 |
GO:0031570 | DNA integrity checkpoint signaling | 6.02% (10/166) | 4.28 | 0.0 | 0.0 |
GO:0051012 | microtubule sliding | 4.22% (7/166) | 5.56 | 0.0 | 0.0 |
GO:0010639 | negative regulation of organelle organization | 7.83% (13/166) | 3.53 | 0.0 | 0.0 |
GO:0000727 | double-strand break repair via break-induced replication | 3.01% (5/166) | 7.03 | 0.0 | 0.0 |
GO:0032886 | regulation of microtubule-based process | 6.63% (11/166) | 3.95 | 0.0 | 0.0 |
GO:0003697 | single-stranded DNA binding | 7.23% (12/166) | 3.7 | 0.0 | 0.0 |
GO:0051656 | establishment of organelle localization | 9.04% (15/166) | 3.15 | 0.0 | 0.0 |
GO:0051640 | organelle localization | 10.24% (17/166) | 2.88 | 0.0 | 0.0 |
GO:0045740 | positive regulation of DNA replication | 4.22% (7/166) | 5.48 | 0.0 | 0.0 |
GO:0065004 | protein-DNA complex assembly | 6.02% (10/166) | 4.18 | 0.0 | 0.0 |
GO:0008094 | ATP-dependent activity, acting on DNA | 7.23% (12/166) | 3.66 | 0.0 | 0.0 |
GO:0003688 | DNA replication origin binding | 3.61% (6/166) | 6.07 | 0.0 | 0.0 |
GO:0031399 | regulation of protein modification process | 13.86% (23/166) | 2.28 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 24.1% (40/166) | 1.55 | 0.0 | 0.0 |
GO:0031503 | protein-containing complex localization | 6.02% (10/166) | 4.07 | 0.0 | 0.0 |
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 4.82% (8/166) | 4.79 | 0.0 | 0.0 |
GO:0033044 | regulation of chromosome organization | 7.83% (13/166) | 3.36 | 0.0 | 0.0 |
GO:0007062 | sister chromatid cohesion | 4.82% (8/166) | 4.73 | 0.0 | 0.0 |
GO:0000281 | mitotic cytokinesis | 5.42% (9/166) | 4.32 | 0.0 | 0.0 |
GO:0140513 | nuclear protein-containing complex | 15.66% (26/166) | 2.04 | 0.0 | 0.0 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 5.42% (9/166) | 4.28 | 0.0 | 0.0 |
GO:0042770 | signal transduction in response to DNA damage | 5.42% (9/166) | 4.27 | 0.0 | 0.0 |
GO:0051783 | regulation of nuclear division | 6.63% (11/166) | 3.68 | 0.0 | 0.0 |
GO:1990234 | transferase complex | 13.25% (22/166) | 2.26 | 0.0 | 0.0 |
GO:0036372 | opsin transport | 2.41% (4/166) | 7.56 | 0.0 | 0.0 |
GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex | 2.41% (4/166) | 7.56 | 0.0 | 0.0 |
GO:0120170 | intraciliary transport particle B binding | 2.41% (4/166) | 7.56 | 0.0 | 0.0 |
GO:0033045 | regulation of sister chromatid segregation | 5.42% (9/166) | 4.22 | 0.0 | 0.0 |
GO:0000347 | THO complex | 3.01% (5/166) | 6.5 | 0.0 | 0.0 |
GO:0007059 | chromosome segregation | 5.42% (9/166) | 4.19 | 0.0 | 0.0 |
GO:1905818 | regulation of chromosome separation | 5.42% (9/166) | 4.18 | 0.0 | 0.0 |
GO:0051338 | regulation of transferase activity | 9.04% (15/166) | 2.89 | 0.0 | 0.0 |
GO:2000105 | positive regulation of DNA-templated DNA replication | 3.61% (6/166) | 5.61 | 0.0 | 0.0 |
GO:0032993 | protein-DNA complex | 6.02% (10/166) | 3.82 | 0.0 | 0.0 |
GO:0000785 | chromatin | 9.04% (15/166) | 2.86 | 0.0 | 0.0 |
GO:0051255 | spindle midzone assembly | 3.01% (5/166) | 6.29 | 0.0 | 0.0 |
GO:1905784 | regulation of anaphase-promoting complex-dependent catabolic process | 3.01% (5/166) | 6.29 | 0.0 | 0.0 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 5.42% (9/166) | 4.04 | 0.0 | 0.0 |
GO:0033206 | meiotic cytokinesis | 4.22% (7/166) | 4.83 | 0.0 | 0.0 |
GO:0031261 | DNA replication preinitiation complex | 3.01% (5/166) | 6.2 | 0.0 | 0.0 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 9.04% (15/166) | 2.79 | 0.0 | 0.0 |
GO:0071103 | DNA conformation change | 5.42% (9/166) | 3.97 | 0.0 | 0.0 |
GO:0051983 | regulation of chromosome segregation | 5.42% (9/166) | 3.96 | 0.0 | 0.0 |
GO:0044772 | mitotic cell cycle phase transition | 5.42% (9/166) | 3.95 | 0.0 | 0.0 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 9.04% (15/166) | 2.74 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 23.49% (39/166) | 1.42 | 0.0 | 0.0 |
GO:0080175 | phragmoplast microtubule organization | 2.41% (4/166) | 7.07 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 50.0% (83/166) | 0.78 | 0.0 | 0.0 |
GO:0071824 | protein-DNA complex subunit organization | 6.02% (10/166) | 3.59 | 0.0 | 0.0 |
GO:0008088 | axo-dendritic transport | 4.22% (7/166) | 4.62 | 0.0 | 0.0 |
GO:0035556 | intracellular signal transduction | 13.25% (22/166) | 2.06 | 0.0 | 0.0 |
GO:0007097 | nuclear migration | 4.22% (7/166) | 4.6 | 0.0 | 0.0 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 7.83% (13/166) | 2.95 | 0.0 | 0.0 |
GO:0000166 | nucleotide binding | 25.3% (42/166) | 1.32 | 0.0 | 0.0 |
GO:1901265 | nucleoside phosphate binding | 25.3% (42/166) | 1.32 | 0.0 | 0.0 |
GO:0031534 | minus-end directed microtubule sliding | 3.01% (5/166) | 5.88 | 0.0 | 0.0 |
GO:0044770 | cell cycle phase transition | 5.42% (9/166) | 3.8 | 0.0 | 0.0 |
GO:0005488 | binding | 71.08% (118/166) | 0.51 | 0.0 | 0.0 |
GO:0006268 | DNA unwinding involved in DNA replication | 3.61% (6/166) | 5.04 | 0.0 | 0.0 |
GO:0051647 | nucleus localization | 4.22% (7/166) | 4.48 | 0.0 | 0.0 |
GO:0008569 | minus-end-directed microtubule motor activity | 3.01% (5/166) | 5.74 | 0.0 | 0.0 |
GO:0065009 | regulation of molecular function | 16.87% (28/166) | 1.7 | 0.0 | 1e-06 |
GO:0005929 | cilium | 5.42% (9/166) | 3.71 | 0.0 | 1e-06 |
GO:0000793 | condensed chromosome | 4.82% (8/166) | 4.03 | 0.0 | 1e-06 |
GO:0098772 | molecular function regulator activity | 12.05% (20/166) | 2.13 | 0.0 | 1e-06 |
GO:0031298 | replication fork protection complex | 2.41% (4/166) | 6.71 | 0.0 | 1e-06 |
GO:0098935 | dendritic transport | 2.41% (4/166) | 6.71 | 0.0 | 1e-06 |
GO:0098937 | anterograde dendritic transport | 2.41% (4/166) | 6.71 | 0.0 | 1e-06 |
GO:0003677 | DNA binding | 22.29% (37/166) | 1.4 | 0.0 | 1e-06 |
GO:0005654 | nucleoplasm | 15.66% (26/166) | 1.78 | 0.0 | 1e-06 |
GO:0032392 | DNA geometric change | 4.82% (8/166) | 4.0 | 0.0 | 1e-06 |
GO:0051054 | positive regulation of DNA metabolic process | 6.02% (10/166) | 3.4 | 0.0 | 1e-06 |
GO:0044818 | mitotic G2/M transition checkpoint | 3.61% (6/166) | 4.88 | 0.0 | 1e-06 |
GO:0051233 | spindle midzone | 3.61% (6/166) | 4.88 | 0.0 | 1e-06 |
GO:0032877 | positive regulation of DNA endoreduplication | 2.41% (4/166) | 6.56 | 0.0 | 1e-06 |
GO:0060255 | regulation of macromolecule metabolic process | 32.53% (54/166) | 1.04 | 0.0 | 1e-06 |
GO:0051649 | establishment of localization in cell | 14.46% (24/166) | 1.84 | 0.0 | 1e-06 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 5.42% (9/166) | 3.59 | 0.0 | 1e-06 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 11.45% (19/166) | 2.14 | 0.0 | 1e-06 |
GO:0051171 | regulation of nitrogen compound metabolic process | 30.72% (51/166) | 1.08 | 0.0 | 1e-06 |
GO:0051129 | negative regulation of cellular component organization | 7.83% (13/166) | 2.74 | 0.0 | 1e-06 |
GO:0007064 | mitotic sister chromatid cohesion | 3.01% (5/166) | 5.45 | 0.0 | 1e-06 |
GO:0080090 | regulation of primary metabolic process | 31.93% (53/166) | 1.04 | 0.0 | 1e-06 |
GO:1902407 | assembly of actomyosin apparatus involved in mitotic cytokinesis | 2.41% (4/166) | 6.42 | 0.0 | 1e-06 |
GO:0051256 | mitotic spindle midzone assembly | 2.41% (4/166) | 6.42 | 0.0 | 1e-06 |
GO:0051445 | regulation of meiotic cell cycle | 4.82% (8/166) | 3.82 | 0.0 | 1e-06 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 4.22% (7/166) | 4.21 | 0.0 | 1e-06 |
GO:0051716 | cellular response to stimulus | 30.72% (51/166) | 1.06 | 0.0 | 2e-06 |
GO:0006139 | nucleobase-containing compound metabolic process | 24.1% (40/166) | 1.25 | 0.0 | 2e-06 |
GO:0051641 | cellular localization | 17.47% (29/166) | 1.56 | 0.0 | 2e-06 |
GO:0033260 | nuclear DNA replication | 2.41% (4/166) | 6.29 | 0.0 | 2e-06 |
GO:0044815 | DNA packaging complex | 4.22% (7/166) | 4.15 | 0.0 | 2e-06 |
GO:0050790 | regulation of catalytic activity | 12.65% (21/166) | 1.94 | 0.0 | 2e-06 |
GO:0007140 | male meiotic nuclear division | 4.22% (7/166) | 4.13 | 0.0 | 2e-06 |
GO:0010965 | regulation of mitotic sister chromatid separation | 4.22% (7/166) | 4.12 | 0.0 | 2e-06 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 3.61% (6/166) | 4.58 | 0.0 | 2e-06 |
GO:0060236 | regulation of mitotic spindle organization | 3.01% (5/166) | 5.25 | 0.0 | 2e-06 |
GO:0008284 | positive regulation of cell population proliferation | 7.83% (13/166) | 2.64 | 0.0 | 2e-06 |
GO:0140013 | meiotic nuclear division | 4.82% (8/166) | 3.71 | 0.0 | 2e-06 |
GO:0042575 | DNA polymerase complex | 2.41% (4/166) | 6.18 | 0.0 | 3e-06 |
GO:0033554 | cellular response to stress | 22.89% (38/166) | 1.27 | 0.0 | 3e-06 |
GO:1990023 | mitotic spindle midzone | 3.01% (5/166) | 5.2 | 0.0 | 3e-06 |
GO:0031401 | positive regulation of protein modification process | 8.43% (14/166) | 2.49 | 0.0 | 3e-06 |
GO:0000922 | spindle pole | 4.22% (7/166) | 4.04 | 0.0 | 3e-06 |
GO:0016462 | pyrophosphatase activity | 7.83% (13/166) | 2.6 | 0.0 | 3e-06 |
GO:0030234 | enzyme regulator activity | 10.24% (17/166) | 2.17 | 0.0 | 3e-06 |
GO:0002204 | somatic recombination of immunoglobulin genes involved in immune response | 1.81% (3/166) | 7.46 | 0.0 | 3e-06 |
GO:0002208 | somatic diversification of immunoglobulins involved in immune response | 1.81% (3/166) | 7.46 | 0.0 | 3e-06 |
GO:0045190 | isotype switching | 1.81% (3/166) | 7.46 | 0.0 | 3e-06 |
GO:0097373 | MCM core complex | 1.81% (3/166) | 7.46 | 0.0 | 3e-06 |
GO:1905463 | negative regulation of DNA duplex unwinding | 1.81% (3/166) | 7.46 | 0.0 | 3e-06 |
GO:0005658 | alpha DNA polymerase:primase complex | 1.81% (3/166) | 7.46 | 0.0 | 3e-06 |
GO:0031535 | plus-end directed microtubule sliding | 1.81% (3/166) | 7.46 | 0.0 | 3e-06 |
GO:0005873 | plus-end kinesin complex | 1.81% (3/166) | 7.46 | 0.0 | 3e-06 |
GO:0051095 | regulation of helicase activity | 2.41% (4/166) | 6.07 | 0.0 | 3e-06 |
GO:0090068 | positive regulation of cell cycle process | 6.02% (10/166) | 3.11 | 0.0 | 3e-06 |
GO:0032508 | DNA duplex unwinding | 4.22% (7/166) | 4.0 | 0.0 | 3e-06 |
GO:0072686 | mitotic spindle | 4.22% (7/166) | 4.0 | 0.0 | 3e-06 |
GO:0036094 | small molecule binding | 25.3% (42/166) | 1.17 | 0.0 | 3e-06 |
GO:1902101 | positive regulation of metaphase/anaphase transition of cell cycle | 3.61% (6/166) | 4.49 | 0.0 | 3e-06 |
GO:1905820 | positive regulation of chromosome separation | 3.61% (6/166) | 4.49 | 0.0 | 3e-06 |
GO:0030261 | chromosome condensation | 3.61% (6/166) | 4.46 | 0.0 | 4e-06 |
GO:0045132 | meiotic chromosome segregation | 3.01% (5/166) | 5.11 | 0.0 | 4e-06 |
GO:0090224 | regulation of spindle organization | 3.01% (5/166) | 5.11 | 0.0 | 4e-06 |
GO:0046907 | intracellular transport | 12.65% (21/166) | 1.87 | 0.0 | 4e-06 |
GO:0030865 | cortical cytoskeleton organization | 5.42% (9/166) | 3.29 | 0.0 | 4e-06 |
GO:0048256 | flap endonuclease activity | 2.41% (4/166) | 5.97 | 0.0 | 4e-06 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 3.61% (6/166) | 4.4 | 0.0 | 5e-06 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 3.61% (6/166) | 4.4 | 0.0 | 5e-06 |
GO:0004386 | helicase activity | 6.02% (10/166) | 3.05 | 0.0 | 5e-06 |
GO:0070192 | chromosome organization involved in meiotic cell cycle | 4.22% (7/166) | 3.92 | 0.0 | 5e-06 |
GO:0045859 | regulation of protein kinase activity | 6.02% (10/166) | 3.03 | 0.0 | 5e-06 |
GO:0007112 | male meiosis cytokinesis | 3.01% (5/166) | 4.99 | 1e-06 | 5e-06 |
GO:1902494 | catalytic complex | 15.06% (25/166) | 1.63 | 1e-06 | 5e-06 |
GO:0006325 | chromatin organization | 7.23% (12/166) | 2.66 | 1e-06 | 5e-06 |
GO:0007076 | mitotic chromosome condensation | 2.41% (4/166) | 5.88 | 1e-06 | 6e-06 |
GO:0016887 | ATP hydrolysis activity | 4.22% (7/166) | 3.88 | 1e-06 | 6e-06 |
GO:0042127 | regulation of cell population proliferation | 10.24% (17/166) | 2.09 | 1e-06 | 6e-06 |
GO:0044786 | cell cycle DNA replication | 3.61% (6/166) | 4.31 | 1e-06 | 6e-06 |
GO:0043226 | organelle | 59.04% (98/166) | 0.56 | 1e-06 | 7e-06 |
GO:0071897 | DNA biosynthetic process | 4.22% (7/166) | 3.83 | 1e-06 | 7e-06 |
GO:1904668 | positive regulation of ubiquitin protein ligase activity | 2.41% (4/166) | 5.79 | 1e-06 | 7e-06 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 3.61% (6/166) | 4.27 | 1e-06 | 7e-06 |
GO:0017076 | purine nucleotide binding | 17.47% (29/166) | 1.45 | 1e-06 | 7e-06 |
GO:0000914 | phragmoplast assembly | 1.81% (3/166) | 7.14 | 1e-06 | 7e-06 |
GO:0006279 | premeiotic DNA replication | 1.81% (3/166) | 7.14 | 1e-06 | 7e-06 |
GO:0051097 | negative regulation of helicase activity | 1.81% (3/166) | 7.14 | 1e-06 | 7e-06 |
GO:0048523 | negative regulation of cellular process | 24.7% (41/166) | 1.14 | 1e-06 | 8e-06 |
GO:0045787 | positive regulation of cell cycle | 6.63% (11/166) | 2.77 | 1e-06 | 8e-06 |
GO:0002285 | lymphocyte activation involved in immune response | 2.41% (4/166) | 5.71 | 1e-06 | 9e-06 |
GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 2.41% (4/166) | 5.71 | 1e-06 | 9e-06 |
GO:0050789 | regulation of biological process | 51.81% (86/166) | 0.63 | 1e-06 | 9e-06 |
GO:0022414 | reproductive process | 33.13% (55/166) | 0.91 | 1e-06 | 9e-06 |
GO:0003341 | cilium movement | 3.01% (5/166) | 4.81 | 1e-06 | 9e-06 |
GO:0051303 | establishment of chromosome localization | 3.61% (6/166) | 4.2 | 1e-06 | 9e-06 |
GO:0001578 | microtubule bundle formation | 3.61% (6/166) | 4.2 | 1e-06 | 9e-06 |
GO:0043549 | regulation of kinase activity | 6.02% (10/166) | 2.91 | 1e-06 | 1e-05 |
GO:0120035 | regulation of plasma membrane bounded cell projection organization | 6.02% (10/166) | 2.91 | 1e-06 | 1e-05 |
GO:0032553 | ribonucleotide binding | 17.47% (29/166) | 1.42 | 1e-06 | 1e-05 |
GO:0009987 | cellular process | 70.48% (117/166) | 0.43 | 1e-06 | 1.1e-05 |
GO:0031323 | regulation of cellular metabolic process | 31.33% (52/166) | 0.94 | 1e-06 | 1.1e-05 |
GO:0017116 | single-stranded DNA helicase activity | 3.01% (5/166) | 4.74 | 1e-06 | 1.2e-05 |
GO:0010332 | response to gamma radiation | 3.61% (6/166) | 4.14 | 1e-06 | 1.2e-05 |
GO:0019899 | enzyme binding | 15.66% (26/166) | 1.51 | 1e-06 | 1.2e-05 |
GO:0016604 | nuclear body | 8.43% (14/166) | 2.28 | 1e-06 | 1.3e-05 |
GO:0031344 | regulation of cell projection organization | 6.02% (10/166) | 2.86 | 1e-06 | 1.3e-05 |
GO:0046649 | lymphocyte activation | 4.22% (7/166) | 3.66 | 1e-06 | 1.4e-05 |
GO:0002312 | B cell activation involved in immune response | 1.81% (3/166) | 6.88 | 1e-06 | 1.4e-05 |
GO:0000796 | condensin complex | 1.81% (3/166) | 6.88 | 1e-06 | 1.4e-05 |
GO:1905186 | regulation of metaphase/anaphase transition of meiosis I | 1.81% (3/166) | 6.88 | 1e-06 | 1.4e-05 |
GO:1905188 | positive regulation of metaphase/anaphase transition of meiosis I | 1.81% (3/166) | 6.88 | 1e-06 | 1.4e-05 |
GO:0035639 | purine ribonucleoside triphosphate binding | 16.27% (27/166) | 1.47 | 2e-06 | 1.4e-05 |
GO:0001932 | regulation of protein phosphorylation | 7.23% (12/166) | 2.52 | 2e-06 | 1.4e-05 |
GO:0000731 | DNA synthesis involved in DNA repair | 3.01% (5/166) | 4.68 | 2e-06 | 1.4e-05 |
GO:1902410 | mitotic cytokinetic process | 3.01% (5/166) | 4.65 | 2e-06 | 1.5e-05 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 3.61% (6/166) | 4.05 | 2e-06 | 1.6e-05 |
GO:0035173 | histone kinase activity | 2.41% (4/166) | 5.49 | 2e-06 | 1.6e-05 |
GO:0032501 | multicellular organismal process | 33.13% (55/166) | 0.88 | 2e-06 | 1.8e-05 |
GO:0032555 | purine ribonucleotide binding | 16.87% (28/166) | 1.41 | 2e-06 | 1.8e-05 |
GO:0006298 | mismatch repair | 3.01% (5/166) | 4.59 | 2e-06 | 1.9e-05 |
GO:0044458 | motile cilium assembly | 2.41% (4/166) | 5.42 | 2e-06 | 1.9e-05 |
GO:0003678 | DNA helicase activity | 4.22% (7/166) | 3.57 | 2e-06 | 2e-05 |
GO:0033679 | 3'-5' DNA/RNA helicase activity | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:1990518 | single-stranded 3'-5' DNA helicase activity | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:1905462 | regulation of DNA duplex unwinding | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0034306 | regulation of sexual sporulation | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0034307 | regulation of ascospore formation | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0042173 | regulation of sporulation resulting in formation of a cellular spore | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0043938 | positive regulation of sporulation | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0043940 | regulation of sexual sporulation resulting in formation of a cellular spore | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0043941 | positive regulation of sexual sporulation resulting in formation of a cellular spore | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0045881 | positive regulation of sporulation resulting in formation of a cellular spore | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0075296 | positive regulation of ascospore formation | 1.81% (3/166) | 6.66 | 3e-06 | 2.2e-05 |
GO:0006301 | postreplication repair | 3.01% (5/166) | 4.53 | 3e-06 | 2.2e-05 |
GO:0007088 | regulation of mitotic nuclear division | 4.22% (7/166) | 3.55 | 3e-06 | 2.2e-05 |
GO:0050000 | chromosome localization | 3.61% (6/166) | 3.93 | 3e-06 | 2.5e-05 |
GO:0019222 | regulation of metabolic process | 34.34% (57/166) | 0.84 | 3e-06 | 2.6e-05 |
GO:0043933 | protein-containing complex organization | 12.65% (21/166) | 1.66 | 3e-06 | 2.8e-05 |
GO:0097367 | carbohydrate derivative binding | 17.47% (29/166) | 1.34 | 3e-06 | 2.8e-05 |
GO:2001251 | negative regulation of chromosome organization | 3.61% (6/166) | 3.89 | 3e-06 | 2.8e-05 |
GO:0045321 | leukocyte activation | 4.22% (7/166) | 3.45 | 4e-06 | 3.3e-05 |
GO:0005915 | zonula adherens | 1.81% (3/166) | 6.46 | 4e-06 | 3.3e-05 |
GO:0045218 | zonula adherens maintenance | 1.81% (3/166) | 6.46 | 4e-06 | 3.3e-05 |
GO:0090136 | epithelial cell-cell adhesion | 1.81% (3/166) | 6.46 | 4e-06 | 3.3e-05 |
GO:0031915 | positive regulation of synaptic plasticity | 1.81% (3/166) | 6.46 | 4e-06 | 3.3e-05 |
GO:1905786 | positive regulation of anaphase-promoting complex-dependent catabolic process | 1.81% (3/166) | 6.46 | 4e-06 | 3.3e-05 |
GO:1990757 | ubiquitin ligase activator activity | 1.81% (3/166) | 6.46 | 4e-06 | 3.3e-05 |
GO:0097124 | cyclin A2-CDK2 complex | 1.81% (3/166) | 6.46 | 4e-06 | 3.3e-05 |
GO:0000077 | DNA damage checkpoint signaling | 3.61% (6/166) | 3.84 | 4e-06 | 3.5e-05 |
GO:0051299 | centrosome separation | 2.41% (4/166) | 5.18 | 4e-06 | 3.5e-05 |
GO:0019985 | translesion synthesis | 2.41% (4/166) | 5.12 | 5e-06 | 4.1e-05 |
GO:0051246 | regulation of protein metabolic process | 15.06% (25/166) | 1.44 | 5e-06 | 4.2e-05 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 22.89% (38/166) | 1.09 | 5e-06 | 4.2e-05 |
GO:0065003 | protein-containing complex assembly | 11.45% (19/166) | 1.72 | 6e-06 | 4.6e-05 |
GO:0010212 | response to ionizing radiation | 4.22% (7/166) | 3.36 | 6e-06 | 4.6e-05 |
GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 2.41% (4/166) | 5.07 | 6e-06 | 4.6e-05 |
GO:2000104 | negative regulation of DNA-templated DNA replication | 2.41% (4/166) | 5.07 | 6e-06 | 4.6e-05 |
GO:0005680 | anaphase-promoting complex | 2.41% (4/166) | 5.07 | 6e-06 | 4.6e-05 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 1.81% (3/166) | 6.29 | 6e-06 | 4.8e-05 |
GO:0002566 | somatic diversification of immune receptors via somatic mutation | 1.81% (3/166) | 6.29 | 6e-06 | 4.8e-05 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 1.81% (3/166) | 6.29 | 6e-06 | 4.8e-05 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 1.81% (3/166) | 6.29 | 6e-06 | 4.8e-05 |
GO:0010342 | endosperm cellularization | 1.81% (3/166) | 6.29 | 6e-06 | 4.8e-05 |
GO:0070306 | lens fiber cell differentiation | 1.81% (3/166) | 6.29 | 6e-06 | 4.8e-05 |
GO:0048471 | perinuclear region of cytoplasm | 6.63% (11/166) | 2.44 | 7e-06 | 5.2e-05 |
GO:0042325 | regulation of phosphorylation | 7.23% (12/166) | 2.3 | 7e-06 | 5.2e-05 |
GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 2.41% (4/166) | 5.02 | 7e-06 | 5.2e-05 |
GO:0003779 | actin binding | 4.82% (8/166) | 3.03 | 7e-06 | 5.2e-05 |
GO:0001775 | cell activation | 4.22% (7/166) | 3.33 | 7e-06 | 5.3e-05 |
GO:0042113 | B cell activation | 3.01% (5/166) | 4.22 | 7e-06 | 5.6e-05 |
GO:0045005 | DNA-templated DNA replication maintenance of fidelity | 3.01% (5/166) | 4.22 | 7e-06 | 5.6e-05 |
GO:0002366 | leukocyte activation involved in immune response | 2.41% (4/166) | 4.97 | 8e-06 | 5.9e-05 |
GO:0051321 | meiotic cell cycle | 5.42% (9/166) | 2.77 | 8e-06 | 6e-05 |
GO:0061982 | meiosis I cell cycle process | 3.61% (6/166) | 3.66 | 9e-06 | 6.5e-05 |
GO:0003351 | epithelial cilium movement involved in extracellular fluid movement | 1.81% (3/166) | 6.14 | 9e-06 | 6.5e-05 |
GO:0090128 | regulation of synapse maturation | 1.81% (3/166) | 6.14 | 9e-06 | 6.5e-05 |
GO:0090129 | positive regulation of synapse maturation | 1.81% (3/166) | 6.14 | 9e-06 | 6.5e-05 |
GO:0002263 | cell activation involved in immune response | 2.41% (4/166) | 4.93 | 9e-06 | 6.6e-05 |
GO:0043138 | 3'-5' DNA helicase activity | 2.41% (4/166) | 4.93 | 9e-06 | 6.6e-05 |
GO:0000278 | mitotic cell cycle | 3.61% (6/166) | 3.64 | 9e-06 | 6.8e-05 |
GO:0030496 | midbody | 3.61% (6/166) | 3.64 | 9e-06 | 6.8e-05 |
GO:0040020 | regulation of meiotic nuclear division | 3.01% (5/166) | 4.16 | 9e-06 | 6.9e-05 |
GO:0043229 | intracellular organelle | 56.63% (94/166) | 0.5 | 1e-05 | 7.2e-05 |
GO:0032153 | cell division site | 3.01% (5/166) | 4.09 | 1.2e-05 | 8.5e-05 |
GO:0006858 | extracellular transport | 1.81% (3/166) | 6.0 | 1.2e-05 | 8.8e-05 |
GO:0097435 | supramolecular fiber organization | 6.02% (10/166) | 2.5 | 1.3e-05 | 9.4e-05 |
GO:0035371 | microtubule plus-end | 2.41% (4/166) | 4.79 | 1.3e-05 | 9.5e-05 |
GO:1901363 | heterocyclic compound binding | 39.76% (66/166) | 0.68 | 1.4e-05 | 9.9e-05 |
GO:0000776 | kinetochore | 3.01% (5/166) | 4.01 | 1.5e-05 | 0.000111 |
GO:0034334 | adherens junction maintenance | 1.81% (3/166) | 5.88 | 1.6e-05 | 0.000113 |
GO:0045217 | cell-cell junction maintenance | 1.81% (3/166) | 5.88 | 1.6e-05 | 0.000113 |
GO:0090231 | regulation of spindle checkpoint | 1.81% (3/166) | 5.88 | 1.6e-05 | 0.000113 |
GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint | 1.81% (3/166) | 5.88 | 1.6e-05 | 0.000113 |
GO:1903504 | regulation of mitotic spindle checkpoint | 1.81% (3/166) | 5.88 | 1.6e-05 | 0.000113 |
GO:0010997 | anaphase-promoting complex binding | 1.81% (3/166) | 5.88 | 1.6e-05 | 0.000113 |
GO:1904146 | positive regulation of meiotic cell cycle process involved in oocyte maturation | 1.81% (3/166) | 5.88 | 1.6e-05 | 0.000113 |
GO:0051130 | positive regulation of cellular component organization | 7.83% (13/166) | 2.06 | 1.7e-05 | 0.000122 |
GO:0097159 | organic cyclic compound binding | 39.76% (66/166) | 0.67 | 1.7e-05 | 0.000122 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1.2% (2/166) | 7.88 | 1.8e-05 | 0.000123 |
GO:0016064 | immunoglobulin mediated immune response | 1.2% (2/166) | 7.88 | 1.8e-05 | 0.000123 |
GO:0019724 | B cell mediated immunity | 1.2% (2/166) | 7.88 | 1.8e-05 | 0.000123 |
GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity | 1.2% (2/166) | 7.88 | 1.8e-05 | 0.000123 |
GO:0007228 | positive regulation of hh target transcription factor activity | 1.2% (2/166) | 7.88 | 1.8e-05 | 0.000123 |
GO:0035301 | Hedgehog signaling complex | 1.2% (2/166) | 7.88 | 1.8e-05 | 0.000123 |
GO:0006338 | chromatin remodeling | 5.42% (9/166) | 2.62 | 1.8e-05 | 0.000123 |
GO:0031122 | cytoplasmic microtubule organization | 4.22% (7/166) | 3.12 | 1.8e-05 | 0.000124 |
GO:0008156 | negative regulation of DNA replication | 2.41% (4/166) | 4.67 | 1.9e-05 | 0.000126 |
GO:0006312 | mitotic recombination | 2.41% (4/166) | 4.67 | 1.9e-05 | 0.000126 |
GO:0004536 | deoxyribonuclease activity | 3.01% (5/166) | 3.93 | 2e-05 | 0.000136 |
GO:0010005 | cortical microtubule, transverse to long axis | 2.41% (4/166) | 4.63 | 2.1e-05 | 0.00014 |
GO:0005828 | kinetochore microtubule | 2.41% (4/166) | 4.63 | 2.1e-05 | 0.00014 |
GO:0033597 | mitotic checkpoint complex | 1.81% (3/166) | 5.76 | 2.1e-05 | 0.00014 |
GO:0043937 | regulation of sporulation | 1.81% (3/166) | 5.76 | 2.1e-05 | 0.00014 |
GO:0051251 | positive regulation of lymphocyte activation | 3.01% (5/166) | 3.88 | 2.4e-05 | 0.000162 |
GO:0004520 | endodeoxyribonuclease activity | 2.41% (4/166) | 4.56 | 2.5e-05 | 0.000169 |
GO:1990752 | microtubule end | 2.41% (4/166) | 4.56 | 2.5e-05 | 0.000169 |
GO:0097120 | receptor localization to synapse | 2.41% (4/166) | 4.56 | 2.5e-05 | 0.000169 |
GO:0006334 | nucleosome assembly | 3.01% (5/166) | 3.86 | 2.6e-05 | 0.00017 |
GO:0032506 | cytokinetic process | 3.01% (5/166) | 3.84 | 2.7e-05 | 0.00018 |
GO:0030332 | cyclin binding | 2.41% (4/166) | 4.52 | 2.8e-05 | 0.000185 |
GO:0098687 | chromosomal region | 4.82% (8/166) | 2.73 | 3.1e-05 | 0.000207 |
GO:0002200 | somatic diversification of immune receptors | 1.81% (3/166) | 5.56 | 3.3e-05 | 0.000214 |
GO:0016445 | somatic diversification of immunoglobulins | 1.81% (3/166) | 5.56 | 3.3e-05 | 0.000214 |
GO:0005912 | adherens junction | 1.81% (3/166) | 5.56 | 3.3e-05 | 0.000214 |
GO:0070182 | DNA polymerase binding | 1.81% (3/166) | 5.56 | 3.3e-05 | 0.000214 |
GO:1905191 | positive regulation of metaphase/anaphase transition of meiosis II | 1.81% (3/166) | 5.56 | 3.3e-05 | 0.000214 |
GO:0010235 | guard mother cell cytokinesis | 1.81% (3/166) | 5.56 | 3.3e-05 | 0.000214 |
GO:0004529 | exodeoxyribonuclease activity | 2.41% (4/166) | 4.45 | 3.4e-05 | 0.00022 |
GO:0016895 | exodeoxyribonuclease activity, producing 5'-phosphomonoesters | 2.41% (4/166) | 4.45 | 3.4e-05 | 0.00022 |
GO:0002696 | positive regulation of leukocyte activation | 3.01% (5/166) | 3.76 | 3.6e-05 | 0.000234 |
GO:0031109 | microtubule polymerization or depolymerization | 2.41% (4/166) | 4.42 | 3.7e-05 | 0.00024 |
GO:0097027 | ubiquitin-protein transferase activator activity | 1.81% (3/166) | 5.46 | 4e-05 | 0.000258 |
GO:1905189 | regulation of metaphase/anaphase transition of meiosis II | 1.81% (3/166) | 5.46 | 4e-05 | 0.000258 |
GO:0043934 | sporulation | 4.82% (8/166) | 2.67 | 4.3e-05 | 0.000275 |
GO:0008047 | enzyme activator activity | 4.82% (8/166) | 2.66 | 4.4e-05 | 0.000281 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 2.41% (4/166) | 4.36 | 4.5e-05 | 0.000282 |
GO:1901970 | positive regulation of mitotic sister chromatid separation | 2.41% (4/166) | 4.36 | 4.5e-05 | 0.000282 |
GO:1904666 | regulation of ubiquitin protein ligase activity | 2.41% (4/166) | 4.32 | 4.9e-05 | 0.000306 |
GO:0030866 | cortical actin cytoskeleton organization | 2.41% (4/166) | 4.32 | 4.9e-05 | 0.000306 |
GO:0065007 | biological regulation | 51.81% (86/166) | 0.5 | 4.9e-05 | 0.000309 |
GO:0009292 | horizontal gene transfer | 3.01% (5/166) | 3.66 | 5e-05 | 0.000313 |
GO:0009294 | DNA-mediated transformation | 3.01% (5/166) | 3.66 | 5e-05 | 0.000313 |
GO:0050867 | positive regulation of cell activation | 3.01% (5/166) | 3.65 | 5.3e-05 | 0.000328 |
GO:0007601 | visual perception | 2.41% (4/166) | 4.29 | 5.3e-05 | 0.000328 |
GO:0034506 | chromosome, centromeric core domain | 1.2% (2/166) | 7.29 | 5.4e-05 | 0.000329 |
GO:0051309 | female meiosis chromosome separation | 1.2% (2/166) | 7.29 | 5.4e-05 | 0.000329 |
GO:0006273 | lagging strand elongation | 1.2% (2/166) | 7.29 | 5.4e-05 | 0.000329 |
GO:1905775 | negative regulation of DNA helicase activity | 1.2% (2/166) | 7.29 | 5.4e-05 | 0.000329 |
GO:0000073 | initial mitotic spindle pole body separation | 1.2% (2/166) | 7.29 | 5.4e-05 | 0.000329 |
GO:0110100 | spindle pole body separation | 1.2% (2/166) | 7.29 | 5.4e-05 | 0.000329 |
GO:0044093 | positive regulation of molecular function | 7.83% (13/166) | 1.9 | 5.4e-05 | 0.000331 |
GO:0051249 | regulation of lymphocyte activation | 3.01% (5/166) | 3.63 | 5.5e-05 | 0.000338 |
GO:0000152 | nuclear ubiquitin ligase complex | 2.41% (4/166) | 4.26 | 5.7e-05 | 0.000349 |
GO:0008022 | protein C-terminus binding | 3.61% (6/166) | 3.18 | 5.8e-05 | 0.00035 |
GO:0045298 | tubulin complex | 1.81% (3/166) | 5.29 | 5.9e-05 | 0.000355 |
GO:0000217 | DNA secondary structure binding | 3.01% (5/166) | 3.6 | 6.1e-05 | 0.00037 |
GO:0050953 | sensory perception of light stimulus | 2.41% (4/166) | 4.24 | 6.2e-05 | 0.000374 |
GO:0070979 | protein K11-linked ubiquitination | 2.41% (4/166) | 4.24 | 6.2e-05 | 0.000374 |
GO:1901989 | positive regulation of cell cycle phase transition | 3.61% (6/166) | 3.13 | 6.9e-05 | 0.000412 |
GO:0034332 | adherens junction organization | 1.81% (3/166) | 5.22 | 6.9e-05 | 0.000416 |
GO:0005575 | cellular_component | 75.3% (125/166) | 0.3 | 7.1e-05 | 0.000424 |
GO:0051494 | negative regulation of cytoskeleton organization | 3.01% (5/166) | 3.54 | 7.4e-05 | 0.000443 |
GO:0051347 | positive regulation of transferase activity | 4.22% (7/166) | 2.79 | 7.8e-05 | 0.000464 |
GO:0009378 | four-way junction helicase activity | 1.81% (3/166) | 5.14 | 8.1e-05 | 0.00048 |
GO:1901995 | positive regulation of meiotic cell cycle phase transition | 1.81% (3/166) | 5.14 | 8.1e-05 | 0.00048 |
GO:1902104 | positive regulation of metaphase/anaphase transition of meiotic cell cycle | 1.81% (3/166) | 5.14 | 8.1e-05 | 0.00048 |
GO:1905134 | positive regulation of meiotic chromosome separation | 1.81% (3/166) | 5.14 | 8.1e-05 | 0.00048 |
GO:0030295 | protein kinase activator activity | 2.41% (4/166) | 4.12 | 8.4e-05 | 0.000495 |
GO:0019220 | regulation of phosphate metabolic process | 7.23% (12/166) | 1.92 | 9e-05 | 0.000528 |
GO:0046483 | heterocycle metabolic process | 24.1% (40/166) | 0.87 | 9.3e-05 | 0.000547 |
GO:0051228 | mitotic spindle disassembly | 1.81% (3/166) | 5.07 | 9.5e-05 | 0.000551 |
GO:0051230 | spindle disassembly | 1.81% (3/166) | 5.07 | 9.5e-05 | 0.000551 |
GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 1.81% (3/166) | 5.07 | 9.5e-05 | 0.000551 |
GO:0045840 | positive regulation of mitotic nuclear division | 2.41% (4/166) | 4.07 | 9.7e-05 | 0.000563 |
GO:0010444 | guard mother cell differentiation | 2.41% (4/166) | 4.07 | 9.7e-05 | 0.000563 |
GO:0005657 | replication fork | 2.41% (4/166) | 4.05 | 0.000104 | 0.000601 |
GO:0019209 | kinase activator activity | 2.41% (4/166) | 4.05 | 0.000104 | 0.000601 |
GO:0051174 | regulation of phosphorus metabolic process | 7.23% (12/166) | 1.9 | 0.000104 | 0.000601 |
GO:0048869 | cellular developmental process | 16.27% (27/166) | 1.12 | 0.000106 | 0.000607 |
GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity | 1.2% (2/166) | 6.88 | 0.000107 | 0.000609 |
GO:1990942 | mitotic metaphase chromosome recapture | 1.2% (2/166) | 6.88 | 0.000107 | 0.000609 |
GO:0021591 | ventricular system development | 1.2% (2/166) | 6.88 | 0.000107 | 0.000609 |
GO:0045478 | fusome organization | 1.2% (2/166) | 6.88 | 0.000107 | 0.000609 |
GO:0032465 | regulation of cytokinesis | 3.01% (5/166) | 3.43 | 0.000106 | 0.000611 |
GO:0033677 | DNA/RNA helicase activity | 1.81% (3/166) | 5.0 | 0.000109 | 0.000618 |
GO:0090344 | obsolete negative regulation of cell aging | 1.81% (3/166) | 5.0 | 0.000109 | 0.000618 |
GO:0043005 | neuron projection | 6.02% (10/166) | 2.12 | 0.000113 | 0.000641 |
GO:0035825 | homologous recombination | 2.41% (4/166) | 4.0 | 0.000119 | 0.000667 |
GO:0044380 | protein localization to cytoskeleton | 2.41% (4/166) | 4.0 | 0.000119 | 0.000667 |
GO:0072698 | protein localization to microtubule cytoskeleton | 2.41% (4/166) | 4.0 | 0.000119 | 0.000667 |
GO:0031023 | microtubule organizing center organization | 2.41% (4/166) | 4.0 | 0.000119 | 0.000667 |
GO:0005524 | ATP binding | 12.65% (21/166) | 1.31 | 0.000122 | 0.000682 |
GO:0032559 | adenyl ribonucleotide binding | 13.25% (22/166) | 1.27 | 0.000125 | 0.000696 |
GO:0000400 | four-way junction DNA binding | 1.81% (3/166) | 4.94 | 0.000125 | 0.000697 |
GO:0034331 | cell junction maintenance | 1.81% (3/166) | 4.94 | 0.000125 | 0.000697 |
GO:0048522 | positive regulation of cellular process | 24.7% (41/166) | 0.84 | 0.000129 | 0.000713 |
GO:0051020 | GTPase binding | 3.61% (6/166) | 2.96 | 0.000134 | 0.000744 |
GO:0030554 | adenyl nucleotide binding | 13.25% (22/166) | 1.26 | 0.000135 | 0.000744 |
GO:0048518 | positive regulation of biological process | 28.92% (48/166) | 0.74 | 0.000139 | 0.000769 |
GO:0043954 | cellular component maintenance | 1.81% (3/166) | 4.88 | 0.000143 | 0.000783 |
GO:1903538 | regulation of meiotic cell cycle process involved in oocyte maturation | 1.81% (3/166) | 4.88 | 0.000143 | 0.000783 |
GO:0003674 | molecular_function | 73.49% (122/166) | 0.3 | 0.000145 | 0.000787 |
GO:0048519 | negative regulation of biological process | 26.51% (44/166) | 0.79 | 0.000144 | 0.000788 |
GO:0055046 | microgametogenesis | 2.41% (4/166) | 3.93 | 0.000144 | 0.00079 |
GO:0051438 | regulation of ubiquitin-protein transferase activity | 2.41% (4/166) | 3.93 | 0.000144 | 0.00079 |
GO:0044877 | protein-containing complex binding | 8.43% (14/166) | 1.67 | 0.000148 | 0.000806 |
GO:0072384 | organelle transport along microtubule | 2.41% (4/166) | 3.9 | 0.000154 | 0.000833 |
GO:0031398 | positive regulation of protein ubiquitination | 3.01% (5/166) | 3.32 | 0.000155 | 0.000836 |
GO:0016444 | somatic cell DNA recombination | 1.81% (3/166) | 4.82 | 0.000162 | 0.000863 |
GO:0043596 | nuclear replication fork | 1.81% (3/166) | 4.82 | 0.000162 | 0.000863 |
GO:1902102 | regulation of metaphase/anaphase transition of meiotic cell cycle | 1.81% (3/166) | 4.82 | 0.000162 | 0.000863 |
GO:1905132 | regulation of meiotic chromosome separation | 1.81% (3/166) | 4.82 | 0.000162 | 0.000863 |
GO:0051305 | chromosome movement towards spindle pole | 1.81% (3/166) | 4.82 | 0.000162 | 0.000863 |
GO:0002694 | regulation of leukocyte activation | 3.01% (5/166) | 3.31 | 0.000161 | 0.000868 |
GO:0051446 | positive regulation of meiotic cell cycle | 2.41% (4/166) | 3.88 | 0.000163 | 0.000872 |
GO:0048236 | plant-type sporogenesis | 3.61% (6/166) | 2.89 | 0.00017 | 0.000904 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 7.23% (12/166) | 1.82 | 0.000172 | 0.000913 |
GO:0048478 | replication fork protection | 1.2% (2/166) | 6.56 | 0.000178 | 0.000933 |
GO:0062033 | positive regulation of mitotic sister chromatid segregation | 1.2% (2/166) | 6.56 | 0.000178 | 0.000933 |
GO:0090233 | negative regulation of spindle checkpoint | 1.2% (2/166) | 6.56 | 0.000178 | 0.000933 |
GO:0140499 | negative regulation of mitotic spindle assembly checkpoint signaling | 1.2% (2/166) | 6.56 | 0.000178 | 0.000933 |
GO:1902426 | deactivation of mitotic spindle assembly checkpoint | 1.2% (2/166) | 6.56 | 0.000178 | 0.000933 |
GO:1901181 | negative regulation of cellular response to caffeine | 1.2% (2/166) | 6.56 | 0.000178 | 0.000933 |
GO:0005901 | caveola | 1.81% (3/166) | 4.76 | 0.000182 | 0.000952 |
GO:0051984 | positive regulation of chromosome segregation | 1.81% (3/166) | 4.76 | 0.000182 | 0.000952 |
GO:0051247 | positive regulation of protein metabolic process | 8.43% (14/166) | 1.64 | 0.000186 | 0.00097 |
GO:0000786 | nucleosome | 2.41% (4/166) | 3.81 | 0.000195 | 0.001017 |
GO:0034641 | cellular nitrogen compound metabolic process | 24.1% (40/166) | 0.82 | 0.000198 | 0.001029 |
GO:0000729 | DNA double-strand break processing | 1.81% (3/166) | 4.71 | 0.000204 | 0.001053 |
GO:0008409 | 5'-3' exonuclease activity | 1.81% (3/166) | 4.71 | 0.000204 | 0.001053 |
GO:0097431 | mitotic spindle pole | 1.81% (3/166) | 4.71 | 0.000204 | 0.001053 |
GO:0044853 | plasma membrane raft | 1.81% (3/166) | 4.71 | 0.000204 | 0.001053 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.41% (4/166) | 3.77 | 0.000219 | 0.001126 |
GO:0050865 | regulation of cell activation | 3.01% (5/166) | 3.2 | 0.000226 | 0.00116 |
GO:1901993 | regulation of meiotic cell cycle phase transition | 1.81% (3/166) | 4.66 | 0.000228 | 0.001166 |
GO:0000076 | DNA replication checkpoint signaling | 1.81% (3/166) | 4.66 | 0.000228 | 0.001166 |
GO:0010638 | positive regulation of organelle organization | 4.82% (8/166) | 2.31 | 0.000236 | 0.001203 |
GO:0030425 | dendrite | 3.61% (6/166) | 2.79 | 0.000249 | 0.00127 |
GO:0009556 | microsporogenesis | 3.01% (5/166) | 3.17 | 0.000251 | 0.001279 |
GO:0047496 | vesicle transport along microtubule | 1.81% (3/166) | 4.61 | 0.000253 | 0.001282 |
GO:0010369 | chromocenter | 1.81% (3/166) | 4.61 | 0.000253 | 0.001282 |
GO:0098534 | centriole assembly | 1.81% (3/166) | 4.61 | 0.000253 | 0.001282 |
GO:0034728 | nucleosome organization | 3.01% (5/166) | 3.16 | 0.00026 | 0.001315 |
GO:0032405 | MutLalpha complex binding | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:0071466 | cellular response to xenobiotic stimulus | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:0016321 | female meiosis chromosome segregation | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:1905774 | regulation of DNA helicase activity | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:0000806 | Y chromosome | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:0097123 | cyclin A1-CDK2 complex | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:0097134 | cyclin E1-CDK2 complex | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:0097135 | cyclin E2-CDK2 complex | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:2000037 | regulation of stomatal complex patterning | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:0010886 | positive regulation of cholesterol storage | 1.2% (2/166) | 6.29 | 0.000266 | 0.001318 |
GO:0008104 | protein localization | 10.84% (18/166) | 1.35 | 0.000278 | 0.001374 |
GO:0005200 | structural constituent of cytoskeleton | 2.41% (4/166) | 3.67 | 0.000286 | 0.001414 |
GO:0031062 | positive regulation of histone methylation | 3.01% (5/166) | 3.11 | 0.000299 | 0.001473 |
GO:0051094 | positive regulation of developmental process | 9.64% (16/166) | 1.44 | 0.000304 | 0.001497 |
GO:0032780 | negative regulation of ATP-dependent activity | 1.81% (3/166) | 4.51 | 0.00031 | 0.001512 |
GO:0031523 | Myb complex | 1.81% (3/166) | 4.51 | 0.00031 | 0.001512 |
GO:0000723 | telomere maintenance | 3.01% (5/166) | 3.1 | 0.000309 | 0.001515 |
GO:0032200 | telomere organization | 3.01% (5/166) | 3.1 | 0.000309 | 0.001515 |
GO:0032535 | regulation of cellular component size | 4.22% (7/166) | 2.46 | 0.000314 | 0.001529 |
GO:0043168 | anion binding | 16.87% (28/166) | 1.0 | 0.000336 | 0.001632 |
GO:0051302 | regulation of cell division | 4.82% (8/166) | 2.22 | 0.000349 | 0.001694 |
GO:0030154 | cell differentiation | 11.45% (19/166) | 1.27 | 0.000358 | 0.001736 |
GO:0032135 | DNA insertion or deletion binding | 1.2% (2/166) | 6.07 | 0.000371 | 0.001776 |
GO:0051307 | meiotic chromosome separation | 1.2% (2/166) | 6.07 | 0.000371 | 0.001776 |
GO:0035720 | intraciliary anterograde transport | 1.2% (2/166) | 6.07 | 0.000371 | 0.001776 |
GO:0000235 | astral microtubule | 1.2% (2/166) | 6.07 | 0.000371 | 0.001776 |
GO:0098725 | symmetric cell division | 1.2% (2/166) | 6.07 | 0.000371 | 0.001776 |
GO:0090619 | meiotic spindle pole | 1.2% (2/166) | 6.07 | 0.000371 | 0.001776 |
GO:0010885 | regulation of cholesterol storage | 1.2% (2/166) | 6.07 | 0.000371 | 0.001776 |
GO:0050871 | positive regulation of B cell activation | 1.81% (3/166) | 4.42 | 0.000374 | 0.001785 |
GO:0003676 | nucleic acid binding | 24.7% (41/166) | 0.76 | 0.000377 | 0.001798 |
GO:0043462 | regulation of ATP-dependent activity | 2.41% (4/166) | 3.56 | 0.000386 | 0.001836 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 10.24% (17/166) | 1.35 | 0.0004 | 0.001901 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.41% (4/166) | 3.54 | 0.000405 | 0.001915 |
GO:0051785 | positive regulation of nuclear division | 2.41% (4/166) | 3.54 | 0.000405 | 0.001915 |
GO:0110165 | cellular anatomical entity | 72.89% (121/166) | 0.28 | 0.000406 | 0.001917 |
GO:0006725 | cellular aromatic compound metabolic process | 25.3% (42/166) | 0.75 | 0.000407 | 0.001919 |
GO:0036297 | interstrand cross-link repair | 1.81% (3/166) | 4.38 | 0.000409 | 0.00192 |
GO:0007094 | mitotic spindle assembly checkpoint signaling | 1.81% (3/166) | 4.38 | 0.000409 | 0.00192 |
GO:0031267 | small GTPase binding | 3.01% (5/166) | 3.0 | 0.000427 | 0.002001 |
GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 3.01% (5/166) | 3.0 | 0.000427 | 0.002001 |
GO:0008150 | biological_process | 74.1% (123/166) | 0.27 | 0.000429 | 0.002004 |
GO:0034293 | sexual sporulation | 3.61% (6/166) | 2.64 | 0.00043 | 0.002006 |
GO:0008297 | single-stranded DNA exodeoxyribonuclease activity | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0150116 | regulation of cell-substrate junction organization | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0032298 | positive regulation of DNA-templated DNA replication initiation | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0046602 | regulation of mitotic centrosome separation | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0010884 | positive regulation of lipid storage | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0020018 | ciliary pocket membrane | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0034381 | plasma lipoprotein particle clearance | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0034383 | low-density lipoprotein particle clearance | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0060142 | regulation of syncytium formation by plasma membrane fusion | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:1901739 | regulation of myoblast fusion | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:1901741 | positive regulation of myoblast fusion | 1.2% (2/166) | 5.88 | 0.000494 | 0.002252 |
GO:0071173 | spindle assembly checkpoint signaling | 1.81% (3/166) | 4.29 | 0.000484 | 0.002257 |
GO:0005829 | cytosol | 24.1% (40/166) | 0.76 | 0.000499 | 0.002271 |
GO:0071174 | mitotic spindle checkpoint signaling | 1.81% (3/166) | 4.25 | 0.000526 | 0.002385 |
GO:0000803 | sex chromosome | 1.81% (3/166) | 4.25 | 0.000526 | 0.002385 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 12.65% (21/166) | 1.15 | 0.000533 | 0.002417 |
GO:0090066 | regulation of anatomical structure size | 4.22% (7/166) | 2.32 | 0.000544 | 0.00246 |
GO:0005667 | transcription regulator complex | 4.22% (7/166) | 2.32 | 0.000554 | 0.0025 |
GO:0010975 | regulation of neuron projection development | 3.61% (6/166) | 2.57 | 0.000564 | 0.002544 |
GO:0050864 | regulation of B cell activation | 1.81% (3/166) | 4.22 | 0.000569 | 0.002556 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.81% (3/166) | 4.22 | 0.000569 | 0.002556 |
GO:0030855 | epithelial cell differentiation | 3.01% (5/166) | 2.89 | 0.000611 | 0.002738 |
GO:0031577 | spindle checkpoint signaling | 1.81% (3/166) | 4.18 | 0.000614 | 0.002751 |
GO:0007534 | gene conversion at mating-type locus | 1.2% (2/166) | 5.71 | 0.000633 | 0.002796 |
GO:0031860 | telomeric 3' overhang formation | 1.2% (2/166) | 5.71 | 0.000633 | 0.002796 |
GO:0006272 | leading strand elongation | 1.2% (2/166) | 5.71 | 0.000633 | 0.002796 |
GO:0099607 | lateral attachment of mitotic spindle microtubules to kinetochore | 1.2% (2/166) | 5.71 | 0.000633 | 0.002796 |
GO:0000940 | outer kinetochore | 1.2% (2/166) | 5.71 | 0.000633 | 0.002796 |
GO:0010376 | stomatal complex formation | 1.2% (2/166) | 5.71 | 0.000633 | 0.002796 |
GO:0031095 | platelet dense tubular network membrane | 1.2% (2/166) | 5.71 | 0.000633 | 0.002796 |
GO:1901387 | positive regulation of voltage-gated calcium channel activity | 1.2% (2/166) | 5.71 | 0.000633 | 0.002796 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 4.82% (8/166) | 2.09 | 0.000649 | 0.002863 |
GO:0031297 | replication fork processing | 1.81% (3/166) | 4.14 | 0.000662 | 0.002896 |
GO:0033046 | negative regulation of sister chromatid segregation | 1.81% (3/166) | 4.14 | 0.000662 | 0.002896 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.81% (3/166) | 4.14 | 0.000662 | 0.002896 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.81% (3/166) | 4.14 | 0.000662 | 0.002896 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.81% (3/166) | 4.14 | 0.000662 | 0.002896 |
GO:0045184 | establishment of protein localization | 8.43% (14/166) | 1.44 | 0.000705 | 0.003077 |
GO:0042826 | histone deacetylase binding | 2.41% (4/166) | 3.32 | 0.000711 | 0.003098 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.81% (3/166) | 4.07 | 0.000765 | 0.003311 |
GO:1905819 | negative regulation of chromosome separation | 1.81% (3/166) | 4.07 | 0.000765 | 0.003311 |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 1.81% (3/166) | 4.07 | 0.000765 | 0.003311 |
GO:0097472 | cyclin-dependent protein kinase activity | 1.81% (3/166) | 4.07 | 0.000765 | 0.003311 |
GO:0032876 | negative regulation of DNA endoreduplication | 1.2% (2/166) | 5.56 | 0.000789 | 0.003394 |
GO:0008309 | double-stranded DNA exodeoxyribonuclease activity | 1.2% (2/166) | 5.56 | 0.000789 | 0.003394 |
GO:0060170 | ciliary membrane | 1.2% (2/166) | 5.56 | 0.000789 | 0.003394 |
GO:0031616 | spindle pole centrosome | 1.2% (2/166) | 5.56 | 0.000789 | 0.003394 |
GO:1901976 | regulation of cell cycle checkpoint | 1.81% (3/166) | 4.04 | 0.000819 | 0.003508 |
GO:0055106 | ubiquitin-protein transferase regulator activity | 1.81% (3/166) | 4.04 | 0.000819 | 0.003508 |
GO:0045839 | negative regulation of mitotic nuclear division | 1.81% (3/166) | 4.04 | 0.000819 | 0.003508 |
GO:0003690 | double-stranded DNA binding | 12.05% (20/166) | 1.13 | 0.000828 | 0.003539 |
GO:0051650 | establishment of vesicle localization | 2.41% (4/166) | 3.25 | 0.000863 | 0.003683 |
GO:0099518 | vesicle cytoskeletal trafficking | 1.81% (3/166) | 4.0 | 0.000877 | 0.003735 |
GO:0051648 | vesicle localization | 2.41% (4/166) | 3.24 | 0.000896 | 0.003811 |
GO:0019900 | kinase binding | 6.63% (11/166) | 1.64 | 0.0009 | 0.003821 |
GO:1902904 | negative regulation of supramolecular fiber organization | 2.41% (4/166) | 3.22 | 0.00093 | 0.003943 |
GO:0051985 | negative regulation of chromosome segregation | 1.81% (3/166) | 3.97 | 0.000936 | 0.003964 |
GO:0048513 | animal organ development | 7.83% (13/166) | 1.47 | 0.000941 | 0.003978 |
GO:0052093 | formation of specialized structure for nutrient acquisition | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:0052096 | formation of syncytium involving giant cell for nutrient acquisition | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:0031115 | negative regulation of microtubule polymerization | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:0003896 | DNA primase activity | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:0019894 | kinesin binding | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:0044396 | actin cortical patch organization | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:0097320 | plasma membrane tubulation | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:1901385 | regulation of voltage-gated calcium channel activity | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:2001137 | positive regulation of endocytic recycling | 1.2% (2/166) | 5.42 | 0.000961 | 0.004 |
GO:0031981 | nuclear lumen | 3.01% (5/166) | 2.74 | 0.000964 | 0.004003 |
GO:0070727 | cellular macromolecule localization | 10.84% (18/166) | 1.19 | 0.00097 | 0.004023 |
GO:0045216 | cell-cell junction organization | 1.81% (3/166) | 3.91 | 0.001063 | 0.004403 |
GO:0010492 | maintenance of shoot apical meristem identity | 2.41% (4/166) | 3.17 | 0.001074 | 0.004442 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 15.06% (25/166) | 0.95 | 0.001105 | 0.00456 |
GO:0051304 | chromosome separation | 1.2% (2/166) | 5.29 | 0.001151 | 0.004698 |
GO:0017108 | 5'-flap endonuclease activity | 1.2% (2/166) | 5.29 | 0.001151 | 0.004698 |
GO:0051010 | microtubule plus-end binding | 1.2% (2/166) | 5.29 | 0.001151 | 0.004698 |
GO:0010245 | radial microtubular system formation | 1.2% (2/166) | 5.29 | 0.001151 | 0.004698 |
GO:0035174 | histone serine kinase activity | 1.2% (2/166) | 5.29 | 0.001151 | 0.004698 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.2% (2/166) | 5.29 | 0.001151 | 0.004698 |
GO:0003924 | GTPase activity | 3.61% (6/166) | 2.37 | 0.001148 | 0.004731 |
GO:1901019 | regulation of calcium ion transmembrane transporter activity | 1.81% (3/166) | 3.85 | 0.001201 | 0.004895 |
GO:0032956 | regulation of actin cytoskeleton organization | 3.01% (5/166) | 2.65 | 0.001261 | 0.005135 |
GO:0007349 | cellularization | 1.81% (3/166) | 3.82 | 0.001273 | 0.005167 |
GO:0098609 | cell-cell adhesion | 1.81% (3/166) | 3.82 | 0.001273 | 0.005167 |
GO:0031058 | positive regulation of histone modification | 3.01% (5/166) | 2.64 | 0.001322 | 0.005357 |
GO:0032404 | mismatch repair complex binding | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0006265 | DNA topological change | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0030875 | rDNA protrusion | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0010032 | meiotic chromosome condensation | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0042276 | error-prone translesion synthesis | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0034453 | microtubule anchoring | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0090160 | Golgi to lysosome transport | 1.2% (2/166) | 5.18 | 0.001356 | 0.00542 |
GO:0010604 | positive regulation of macromolecule metabolic process | 15.66% (26/166) | 0.9 | 0.001426 | 0.005681 |
GO:0043085 | positive regulation of catalytic activity | 4.82% (8/166) | 1.91 | 0.001424 | 0.005685 |
GO:0002699 | positive regulation of immune effector process | 2.41% (4/166) | 3.05 | 0.001456 | 0.005785 |
GO:0048872 | homeostasis of number of cells | 2.41% (4/166) | 3.05 | 0.001456 | 0.005785 |
GO:0051310 | metaphase plate congression | 1.81% (3/166) | 3.74 | 0.001508 | 0.005981 |
GO:0016192 | vesicle-mediated transport | 7.23% (12/166) | 1.46 | 0.001538 | 0.00609 |
GO:0001701 | in utero embryonic development | 2.41% (4/166) | 3.02 | 0.001552 | 0.00614 |
GO:0044111 | formation of structure involved in a symbiotic process | 1.2% (2/166) | 5.07 | 0.001578 | 0.006184 |
GO:0035822 | gene conversion | 1.2% (2/166) | 5.07 | 0.001578 | 0.006184 |
GO:0051383 | kinetochore organization | 1.2% (2/166) | 5.07 | 0.001578 | 0.006184 |
GO:0000805 | X chromosome | 1.2% (2/166) | 5.07 | 0.001578 | 0.006184 |
GO:0002088 | lens development in camera-type eye | 1.2% (2/166) | 5.07 | 0.001578 | 0.006184 |
GO:0016572 | obsolete histone phosphorylation | 1.2% (2/166) | 5.07 | 0.001578 | 0.006184 |
GO:0036477 | somatodendritic compartment | 1.81% (3/166) | 3.71 | 0.001592 | 0.006229 |
GO:0043170 | macromolecule metabolic process | 32.53% (54/166) | 0.54 | 0.001637 | 0.006398 |
GO:0042995 | cell projection | 8.43% (14/166) | 1.31 | 0.001742 | 0.0068 |
GO:1903078 | positive regulation of protein localization to plasma membrane | 1.81% (3/166) | 3.66 | 0.001768 | 0.006888 |
GO:0005635 | nuclear envelope | 3.01% (5/166) | 2.54 | 0.001771 | 0.006889 |
GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 1.2% (2/166) | 4.97 | 0.001815 | 0.007001 |
GO:1901977 | negative regulation of cell cycle checkpoint | 1.2% (2/166) | 4.97 | 0.001815 | 0.007001 |
GO:0060122 | inner ear receptor cell stereocilium organization | 1.2% (2/166) | 4.97 | 0.001815 | 0.007001 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 1.2% (2/166) | 4.97 | 0.001815 | 0.007001 |
GO:0086036 | regulation of cardiac muscle cell membrane potential | 1.2% (2/166) | 4.97 | 0.001815 | 0.007001 |
GO:0032970 | regulation of actin filament-based process | 3.01% (5/166) | 2.54 | 0.001809 | 0.007029 |
GO:1904377 | positive regulation of protein localization to cell periphery | 1.81% (3/166) | 3.63 | 0.00186 | 0.007164 |
GO:0015629 | actin cytoskeleton | 2.41% (4/166) | 2.94 | 0.001924 | 0.007387 |
GO:0004527 | exonuclease activity | 2.41% (4/166) | 2.94 | 0.001924 | 0.007387 |
GO:0032272 | negative regulation of protein polymerization | 1.81% (3/166) | 3.61 | 0.001955 | 0.007499 |
GO:0000287 | magnesium ion binding | 4.22% (7/166) | 2.0 | 0.002015 | 0.007716 |
GO:0051784 | negative regulation of nuclear division | 1.81% (3/166) | 3.58 | 0.002054 | 0.00783 |
GO:0007127 | meiosis I | 1.81% (3/166) | 3.58 | 0.002054 | 0.00783 |
GO:0035312 | 5'-3' exodeoxyribonuclease activity | 1.2% (2/166) | 4.88 | 0.002069 | 0.007842 |
GO:0007079 | mitotic chromosome movement towards spindle pole | 1.2% (2/166) | 4.88 | 0.002069 | 0.007842 |
GO:0034498 | early endosome to Golgi transport | 1.2% (2/166) | 4.88 | 0.002069 | 0.007842 |
GO:0031396 | regulation of protein ubiquitination | 3.01% (5/166) | 2.49 | 0.002054 | 0.007853 |
GO:0051179 | localization | 21.69% (36/166) | 0.7 | 0.002081 | 0.007866 |
GO:0005730 | nucleolus | 8.43% (14/166) | 1.28 | 0.00208 | 0.007872 |
GO:0016049 | cell growth | 9.64% (16/166) | 1.18 | 0.002068 | 0.007874 |
GO:0030139 | endocytic vesicle | 3.01% (5/166) | 2.49 | 0.002097 | 0.007914 |
GO:0002697 | regulation of immune effector process | 2.41% (4/166) | 2.9 | 0.0021 | 0.007916 |
GO:0005525 | GTP binding | 3.61% (6/166) | 2.19 | 0.002145 | 0.008074 |
GO:0000781 | chromosome, telomeric region | 2.41% (4/166) | 2.88 | 0.002224 | 0.008358 |
GO:0045003 | double-strand break repair via synthesis-dependent strand annealing | 1.2% (2/166) | 4.79 | 0.002338 | 0.008701 |
GO:0098840 | protein transport along microtubule | 1.2% (2/166) | 4.79 | 0.002338 | 0.008701 |
GO:0099118 | microtubule-based protein transport | 1.2% (2/166) | 4.79 | 0.002338 | 0.008701 |
GO:0007135 | meiosis II | 1.2% (2/166) | 4.79 | 0.002338 | 0.008701 |
GO:0061983 | meiosis II cell cycle process | 1.2% (2/166) | 4.79 | 0.002338 | 0.008701 |
GO:2000123 | positive regulation of stomatal complex development | 1.2% (2/166) | 4.79 | 0.002338 | 0.008701 |
GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 1.2% (2/166) | 4.79 | 0.002338 | 0.008701 |
GO:0060627 | regulation of vesicle-mediated transport | 4.22% (7/166) | 1.96 | 0.002365 | 0.008787 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.01% (5/166) | 2.45 | 0.002369 | 0.00879 |
GO:0043065 | positive regulation of apoptotic process | 3.01% (5/166) | 2.43 | 0.002465 | 0.009134 |
GO:0050773 | regulation of dendrite development | 1.81% (3/166) | 3.49 | 0.002478 | 0.00917 |
GO:1901360 | organic cyclic compound metabolic process | 25.3% (42/166) | 0.62 | 0.0025 | 0.009239 |
GO:0017145 | stem cell division | 1.81% (3/166) | 3.46 | 0.002592 | 0.009551 |
GO:0031325 | positive regulation of cellular metabolic process | 15.06% (25/166) | 0.86 | 0.002588 | 0.009552 |
GO:0007600 | sensory perception | 2.41% (4/166) | 2.81 | 0.002625 | 0.009632 |
GO:1901992 | positive regulation of mitotic cell cycle phase transition | 2.41% (4/166) | 2.81 | 0.002625 | 0.009632 |
GO:1903358 | regulation of Golgi organization | 1.2% (2/166) | 4.71 | 0.002623 | 0.009653 |
GO:0051234 | establishment of localization | 19.28% (32/166) | 0.73 | 0.002661 | 0.009751 |
GO:0030029 | actin filament-based process | 3.01% (5/166) | 2.39 | 0.00277 | 0.010137 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.81% (3/166) | 3.42 | 0.002829 | 0.01031 |
GO:1905477 | positive regulation of protein localization to membrane | 1.81% (3/166) | 3.42 | 0.002829 | 0.01031 |
GO:1990778 | protein localization to cell periphery | 3.01% (5/166) | 2.39 | 0.002823 | 0.010318 |
GO:0006357 | regulation of transcription by RNA polymerase II | 8.43% (14/166) | 1.23 | 0.002863 | 0.010419 |
GO:0140719 | constitutive heterochromatin formation | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:0030473 | nuclear migration along microtubule | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:0060968 | obsolete regulation of gene silencing | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:0045622 | regulation of T-helper cell differentiation | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:0045624 | positive regulation of T-helper cell differentiation | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:1903779 | regulation of cardiac conduction | 1.2% (2/166) | 4.63 | 0.002923 | 0.010481 |
GO:0007409 | axonogenesis | 1.81% (3/166) | 3.4 | 0.002952 | 0.010543 |
GO:0031967 | organelle envelope | 7.23% (12/166) | 1.35 | 0.002949 | 0.010545 |
GO:0031975 | envelope | 7.23% (12/166) | 1.35 | 0.002949 | 0.010545 |
GO:0060341 | regulation of cellular localization | 5.42% (9/166) | 1.62 | 0.002912 | 0.010584 |
GO:0034502 | protein localization to chromosome | 1.81% (3/166) | 3.38 | 0.003079 | 0.01098 |
GO:0000902 | cell morphogenesis | 9.04% (15/166) | 1.16 | 0.003114 | 0.011089 |
GO:0043622 | cortical microtubule organization | 2.41% (4/166) | 2.74 | 0.003152 | 0.01121 |
GO:0031060 | regulation of histone methylation | 3.01% (5/166) | 2.35 | 0.003159 | 0.011221 |
GO:0033036 | macromolecule localization | 10.84% (18/166) | 1.03 | 0.003186 | 0.011301 |
GO:0002250 | adaptive immune response | 1.2% (2/166) | 4.56 | 0.003239 | 0.011397 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.2% (2/166) | 4.56 | 0.003239 | 0.011397 |
GO:0007099 | centriole replication | 1.2% (2/166) | 4.56 | 0.003239 | 0.011397 |
GO:1990511 | piRNA biosynthetic process | 1.2% (2/166) | 4.56 | 0.003239 | 0.011397 |
GO:0045169 | fusome | 1.2% (2/166) | 4.56 | 0.003239 | 0.011397 |
GO:2001135 | regulation of endocytic recycling | 1.2% (2/166) | 4.56 | 0.003239 | 0.011397 |
GO:0051050 | positive regulation of transport | 4.82% (8/166) | 1.72 | 0.003255 | 0.011437 |
GO:0071310 | cellular response to organic substance | 9.04% (15/166) | 1.15 | 0.003263 | 0.011452 |
GO:0051574 | positive regulation of histone H3-K9 methylation | 1.81% (3/166) | 3.34 | 0.003342 | 0.011699 |
GO:0032561 | guanyl ribonucleotide binding | 3.61% (6/166) | 2.06 | 0.003339 | 0.011703 |
GO:0008186 | ATP-dependent activity, acting on RNA | 2.41% (4/166) | 2.71 | 0.003398 | 0.011863 |
GO:0000228 | nuclear chromosome | 2.41% (4/166) | 2.71 | 0.003398 | 0.011863 |
GO:0044843 | cell cycle G1/S phase transition | 1.81% (3/166) | 3.31 | 0.003479 | 0.012129 |
GO:0019001 | guanyl nucleotide binding | 3.61% (6/166) | 2.05 | 0.003486 | 0.012137 |
GO:0019901 | protein kinase binding | 4.82% (8/166) | 1.7 | 0.003538 | 0.0123 |
GO:0015031 | protein transport | 7.23% (12/166) | 1.31 | 0.003547 | 0.012317 |
GO:0000712 | resolution of meiotic recombination intermediates | 1.2% (2/166) | 4.49 | 0.00357 | 0.012333 |
GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation | 1.2% (2/166) | 4.49 | 0.00357 | 0.012333 |
GO:0001881 | receptor recycling | 1.2% (2/166) | 4.49 | 0.00357 | 0.012333 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 1.2% (2/166) | 4.49 | 0.00357 | 0.012333 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 1.81% (3/166) | 3.29 | 0.003619 | 0.012437 |
GO:0060491 | regulation of cell projection assembly | 1.81% (3/166) | 3.29 | 0.003619 | 0.012437 |
GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 1.81% (3/166) | 3.29 | 0.003619 | 0.012437 |
GO:0017053 | transcription repressor complex | 1.81% (3/166) | 3.29 | 0.003619 | 0.012437 |
GO:0005856 | cytoskeleton | 4.82% (8/166) | 1.68 | 0.0038 | 0.013043 |
GO:0002449 | lymphocyte mediated immunity | 1.2% (2/166) | 4.42 | 0.003916 | 0.013319 |
GO:0042641 | actomyosin | 1.2% (2/166) | 4.42 | 0.003916 | 0.013319 |
GO:0140014 | mitotic nuclear division | 1.2% (2/166) | 4.42 | 0.003916 | 0.013319 |
GO:0051602 | response to electrical stimulus | 1.2% (2/166) | 4.42 | 0.003916 | 0.013319 |
GO:0071732 | cellular response to nitric oxide | 1.2% (2/166) | 4.42 | 0.003916 | 0.013319 |
GO:0046637 | regulation of alpha-beta T cell differentiation | 1.2% (2/166) | 4.42 | 0.003916 | 0.013319 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 1.2% (2/166) | 4.42 | 0.003916 | 0.013319 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 3.01% (5/166) | 2.26 | 0.004055 | 0.013773 |
GO:0003696 | satellite DNA binding | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0021707 | cerebellar granule cell differentiation | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0045870 | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0061760 | antifungal innate immune response | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:1903342 | negative regulation of meiotic DNA double-strand break formation | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0043626 | PCNA complex | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0044796 | DNA polymerase processivity factor complex | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0070557 | PCNA-p21 complex | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0061638 | CENP-A containing chromatin | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0022010 | central nervous system myelination | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0032053 | ciliary basal body organization | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0032291 | axon ensheathment in central nervous system | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0036445 | neuronal stem cell division | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0097154 | GABAergic neuron differentiation | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0090102 | cochlea development | 0.6% (1/166) | 7.88 | 0.004247 | 0.014099 |
GO:0045191 | regulation of isotype switching | 1.2% (2/166) | 4.36 | 0.004277 | 0.014165 |
GO:0045830 | positive regulation of isotype switching | 1.2% (2/166) | 4.36 | 0.004277 | 0.014165 |
GO:0034330 | cell junction organization | 2.41% (4/166) | 2.61 | 0.004315 | 0.014271 |
GO:0051258 | protein polymerization | 1.81% (3/166) | 3.22 | 0.004214 | 0.014276 |
GO:0032869 | cellular response to insulin stimulus | 1.81% (3/166) | 3.22 | 0.004214 | 0.014276 |
GO:0140535 | intracellular protein-containing complex | 6.63% (11/166) | 1.35 | 0.004232 | 0.014318 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 3.01% (5/166) | 2.24 | 0.004415 | 0.014565 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 4.82% (8/166) | 1.64 | 0.004414 | 0.014582 |
GO:0002712 | regulation of B cell mediated immunity | 1.2% (2/166) | 4.29 | 0.004653 | 0.015219 |
GO:0002714 | positive regulation of B cell mediated immunity | 1.2% (2/166) | 4.29 | 0.004653 | 0.015219 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 1.2% (2/166) | 4.29 | 0.004653 | 0.015219 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.2% (2/166) | 4.29 | 0.004653 | 0.015219 |
GO:0031113 | regulation of microtubule polymerization | 1.2% (2/166) | 4.29 | 0.004653 | 0.015219 |
GO:0016458 | obsolete gene silencing | 1.2% (2/166) | 4.29 | 0.004653 | 0.015219 |
GO:1904427 | positive regulation of calcium ion transmembrane transport | 1.2% (2/166) | 4.29 | 0.004653 | 0.015219 |
GO:0007030 | Golgi organization | 2.41% (4/166) | 2.58 | 0.004724 | 0.01543 |
GO:0051053 | negative regulation of DNA metabolic process | 2.41% (4/166) | 2.57 | 0.00483 | 0.015758 |
GO:0008589 | regulation of smoothened signaling pathway | 1.81% (3/166) | 3.14 | 0.004864 | 0.015831 |
GO:0031100 | animal organ regeneration | 1.81% (3/166) | 3.14 | 0.004864 | 0.015831 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 1.2% (2/166) | 4.24 | 0.005044 | 0.016295 |
GO:1902855 | regulation of non-motile cilium assembly | 1.2% (2/166) | 4.24 | 0.005044 | 0.016295 |
GO:0045880 | positive regulation of smoothened signaling pathway | 1.2% (2/166) | 4.24 | 0.005044 | 0.016295 |
GO:0001891 | phagocytic cup | 1.2% (2/166) | 4.24 | 0.005044 | 0.016295 |
GO:0048566 | embryonic digestive tract development | 1.2% (2/166) | 4.24 | 0.005044 | 0.016295 |
GO:2001259 | positive regulation of cation channel activity | 1.2% (2/166) | 4.24 | 0.005044 | 0.016295 |
GO:0005700 | polytene chromosome | 1.81% (3/166) | 3.11 | 0.005211 | 0.016774 |
GO:0032355 | response to estradiol | 1.81% (3/166) | 3.11 | 0.005211 | 0.016774 |
GO:0019904 | protein domain specific binding | 4.82% (8/166) | 1.6 | 0.0052 | 0.016778 |
GO:0071375 | cellular response to peptide hormone stimulus | 1.81% (3/166) | 3.09 | 0.00539 | 0.017328 |
GO:0005925 | focal adhesion | 1.2% (2/166) | 4.18 | 0.005449 | 0.017434 |
GO:0072699 | protein localization to cortical microtubule cytoskeleton | 1.2% (2/166) | 4.18 | 0.005449 | 0.017434 |
GO:0045582 | positive regulation of T cell differentiation | 1.2% (2/166) | 4.18 | 0.005449 | 0.017434 |
GO:0048536 | spleen development | 1.2% (2/166) | 4.18 | 0.005449 | 0.017434 |
GO:0010976 | positive regulation of neuron projection development | 1.81% (3/166) | 3.07 | 0.005572 | 0.017806 |
GO:0030036 | actin cytoskeleton organization | 2.41% (4/166) | 2.5 | 0.005618 | 0.017931 |
GO:0042393 | histone binding | 3.01% (5/166) | 2.15 | 0.005719 | 0.018231 |
GO:0030983 | mismatched DNA binding | 1.2% (2/166) | 4.12 | 0.005869 | 0.018619 |
GO:0002443 | leukocyte mediated immunity | 1.2% (2/166) | 4.12 | 0.005869 | 0.018619 |
GO:0090306 | meiotic spindle assembly | 1.2% (2/166) | 4.12 | 0.005869 | 0.018619 |
GO:0048538 | thymus development | 1.2% (2/166) | 4.12 | 0.005869 | 0.018619 |
GO:0045931 | positive regulation of mitotic cell cycle | 2.41% (4/166) | 2.48 | 0.00598 | 0.018951 |
GO:0071345 | cellular response to cytokine stimulus | 3.01% (5/166) | 2.12 | 0.006083 | 0.019253 |
GO:0008361 | regulation of cell size | 2.41% (4/166) | 2.47 | 0.006105 | 0.019299 |
GO:1903169 | regulation of calcium ion transmembrane transport | 1.81% (3/166) | 3.02 | 0.006141 | 0.019391 |
GO:0061136 | regulation of proteasomal protein catabolic process | 3.01% (5/166) | 2.12 | 0.006176 | 0.019479 |
GO:1990814 | DNA/DNA annealing activity | 1.2% (2/166) | 4.07 | 0.006302 | 0.019782 |
GO:0030055 | cell-substrate junction | 1.2% (2/166) | 4.07 | 0.006302 | 0.019782 |
GO:0051177 | meiotic sister chromatid cohesion | 1.2% (2/166) | 4.07 | 0.006302 | 0.019782 |
GO:0034587 | piRNA metabolic process | 1.2% (2/166) | 4.07 | 0.006302 | 0.019782 |
GO:0120025 | plasma membrane bounded cell projection | 7.23% (12/166) | 1.2 | 0.006374 | 0.019984 |
GO:0006352 | DNA-templated transcription initiation | 1.81% (3/166) | 2.99 | 0.006539 | 0.020477 |
GO:0033365 | protein localization to organelle | 5.42% (9/166) | 1.43 | 0.006609 | 0.02067 |
GO:1990823 | response to leukemia inhibitory factor | 1.81% (3/166) | 2.96 | 0.006953 | 0.021694 |
GO:1990830 | cellular response to leukemia inhibitory factor | 1.81% (3/166) | 2.96 | 0.006953 | 0.021694 |
GO:0000819 | sister chromatid segregation | 1.2% (2/166) | 3.97 | 0.007213 | 0.022347 |
GO:0072697 | protein localization to cell cortex | 1.2% (2/166) | 3.97 | 0.007213 | 0.022347 |
GO:0045621 | positive regulation of lymphocyte differentiation | 1.2% (2/166) | 3.97 | 0.007213 | 0.022347 |
GO:0046634 | regulation of alpha-beta T cell activation | 1.2% (2/166) | 3.97 | 0.007213 | 0.022347 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 1.2% (2/166) | 3.97 | 0.007213 | 0.022347 |
GO:0042632 | cholesterol homeostasis | 1.2% (2/166) | 3.97 | 0.007213 | 0.022347 |
GO:0007165 | signal transduction | 16.87% (28/166) | 0.69 | 0.007258 | 0.022462 |
GO:0051570 | regulation of histone H3-K9 methylation | 1.81% (3/166) | 2.93 | 0.007381 | 0.022815 |
GO:0031099 | regeneration | 2.41% (4/166) | 2.39 | 0.007442 | 0.022978 |
GO:0048167 | regulation of synaptic plasticity | 1.81% (3/166) | 2.91 | 0.007601 | 0.02344 |
GO:0042552 | myelination | 1.2% (2/166) | 3.93 | 0.007689 | 0.023629 |
GO:0010824 | regulation of centrosome duplication | 1.2% (2/166) | 3.93 | 0.007689 | 0.023629 |
GO:0090398 | cellular senescence | 1.2% (2/166) | 3.93 | 0.007689 | 0.023629 |
GO:1903076 | regulation of protein localization to plasma membrane | 1.81% (3/166) | 2.89 | 0.007825 | 0.024018 |
GO:0000428 | DNA-directed RNA polymerase complex | 1.81% (3/166) | 2.88 | 0.008052 | 0.024688 |
GO:0032143 | single thymine insertion binding | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0032301 | MutSalpha complex | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1904931 | MCM complex binding | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0032014 | positive regulation of ARF protein signal transduction | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0051549 | positive regulation of keratinocyte migration | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0120182 | regulation of focal adhesion disassembly | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0120183 | positive regulation of focal adhesion disassembly | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0150117 | positive regulation of cell-substrate junction organization | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1903031 | regulation of microtubule plus-end binding | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1903033 | positive regulation of microtubule plus-end binding | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1904825 | protein localization to microtubule plus-end | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1905721 | mitotic spindle astral microtubule end | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1905725 | protein localization to microtubule end | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0032797 | SMN complex | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0005119 | smoothened binding | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0043111 | replication fork arrest | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0001946 | lymphangiogenesis | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0010938 | cytoplasmic microtubule depolymerization | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0060404 | axonemal microtubule depolymerization | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0061523 | cilium disassembly | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0070463 | tubulin-dependent ATPase activity | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0140210 | protein transport along microtubule to kinetochore | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1990295 | post-anaphase microtubule array | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1990758 | mitotic sister chromatid biorientation | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0022038 | corpus callosum development | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0090660 | cerebrospinal fluid circulation | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0010457 | centriole-centriole cohesion | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0021904 | dorsal/ventral neural tube patterning | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0036334 | epidermal stem cell homeostasis | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0043053 | dauer entry | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0055115 | entry into diapause | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0005872 | minus-end kinesin complex | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0034631 | microtubule anchoring at spindle pole body | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0072382 | minus-end-directed vesicle transport along microtubule | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:0090561 | nuclear migration during mitotic telophase | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:1990810 | microtubule anchoring at mitotic spindle pole body | 0.6% (1/166) | 6.88 | 0.008476 | 0.024699 |
GO:2001257 | regulation of cation channel activity | 1.81% (3/166) | 2.85 | 0.008519 | 0.024743 |
GO:0009934 | regulation of meristem structural organization | 1.81% (3/166) | 2.85 | 0.008519 | 0.024743 |
GO:0040007 | growth | 10.24% (17/166) | 0.93 | 0.008519 | 0.024798 |
GO:0045892 | negative regulation of DNA-templated transcription | 7.23% (12/166) | 1.15 | 0.008562 | 0.024842 |
GO:0007272 | ensheathment of neurons | 1.2% (2/166) | 3.88 | 0.008179 | 0.024932 |
GO:0008366 | axon ensheathment | 1.2% (2/166) | 3.88 | 0.008179 | 0.024932 |
GO:2000603 | regulation of secondary growth | 1.2% (2/166) | 3.88 | 0.008179 | 0.024932 |
GO:2000605 | positive regulation of secondary growth | 1.2% (2/166) | 3.88 | 0.008179 | 0.024932 |
GO:0045580 | regulation of T cell differentiation | 1.2% (2/166) | 3.88 | 0.008179 | 0.024932 |
GO:0140666 | annealing activity | 1.2% (2/166) | 3.84 | 0.008682 | 0.02508 |
GO:1902017 | regulation of cilium assembly | 1.2% (2/166) | 3.84 | 0.008682 | 0.02508 |
GO:0051928 | positive regulation of calcium ion transport | 1.2% (2/166) | 3.84 | 0.008682 | 0.02508 |
GO:0061512 | protein localization to cilium | 1.2% (2/166) | 3.84 | 0.008682 | 0.02508 |
GO:0003684 | damaged DNA binding | 1.81% (3/166) | 2.86 | 0.008284 | 0.025223 |
GO:0031333 | negative regulation of protein-containing complex assembly | 1.81% (3/166) | 2.84 | 0.008758 | 0.025272 |
GO:0050804 | modulation of chemical synaptic transmission | 2.41% (4/166) | 2.34 | 0.008331 | 0.025308 |
GO:0099177 | regulation of trans-synaptic signaling | 2.41% (4/166) | 2.34 | 0.008331 | 0.025308 |
GO:0016363 | nuclear matrix | 1.81% (3/166) | 2.82 | 0.009001 | 0.025945 |
GO:1902679 | negative regulation of RNA biosynthetic process | 7.23% (12/166) | 1.14 | 0.009074 | 0.026096 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 7.23% (12/166) | 1.14 | 0.009074 | 0.026096 |
GO:0006959 | humoral immune response | 1.2% (2/166) | 3.79 | 0.009199 | 0.026258 |
GO:0046605 | regulation of centrosome cycle | 1.2% (2/166) | 3.79 | 0.009199 | 0.026258 |
GO:0051211 | anisotropic cell growth | 1.2% (2/166) | 3.79 | 0.009199 | 0.026258 |
GO:0070741 | response to interleukin-6 | 1.2% (2/166) | 3.79 | 0.009199 | 0.026258 |
GO:0071354 | cellular response to interleukin-6 | 1.2% (2/166) | 3.79 | 0.009199 | 0.026258 |
GO:0045171 | intercellular bridge | 1.2% (2/166) | 3.79 | 0.009199 | 0.026258 |
GO:0009893 | positive regulation of metabolic process | 15.66% (26/166) | 0.7 | 0.009199 | 0.026427 |
GO:0031346 | positive regulation of cell projection organization | 2.41% (4/166) | 2.29 | 0.009452 | 0.02695 |
GO:0002639 | positive regulation of immunoglobulin production | 1.2% (2/166) | 3.75 | 0.00973 | 0.027653 |
GO:0046785 | microtubule polymerization | 1.2% (2/166) | 3.75 | 0.00973 | 0.027653 |
GO:0035282 | segmentation | 1.2% (2/166) | 3.75 | 0.00973 | 0.027653 |
GO:0032271 | regulation of protein polymerization | 1.81% (3/166) | 2.78 | 0.009754 | 0.027694 |
GO:0008283 | cell population proliferation | 2.41% (4/166) | 2.26 | 0.009961 | 0.028219 |
GO:0043009 | chordate embryonic development | 2.41% (4/166) | 2.26 | 0.009961 | 0.028219 |
GO:1904375 | regulation of protein localization to cell periphery | 1.81% (3/166) | 2.76 | 0.010013 | 0.028337 |
GO:0030880 | RNA polymerase complex | 1.81% (3/166) | 2.75 | 0.010276 | 0.028896 |
GO:0002637 | regulation of immunoglobulin production | 1.2% (2/166) | 3.71 | 0.010274 | 0.028919 |
GO:0005814 | centriole | 1.2% (2/166) | 3.71 | 0.010274 | 0.028919 |
GO:0000212 | meiotic spindle organization | 1.2% (2/166) | 3.71 | 0.010274 | 0.028919 |
GO:0031571 | mitotic G1 DNA damage checkpoint signaling | 1.2% (2/166) | 3.71 | 0.010274 | 0.028919 |
GO:0007141 | male meiosis I | 1.2% (2/166) | 3.71 | 0.010274 | 0.028919 |
GO:0098590 | plasma membrane region | 4.82% (8/166) | 1.43 | 0.010412 | 0.029247 |
GO:0005634 | nucleus | 21.08% (35/166) | 0.57 | 0.010439 | 0.02929 |
GO:1903008 | organelle disassembly | 1.81% (3/166) | 2.72 | 0.010814 | 0.03028 |
GO:1903050 | regulation of proteolysis involved in protein catabolic process | 3.01% (5/166) | 1.92 | 0.010803 | 0.030281 |
GO:0044819 | mitotic G1/S transition checkpoint signaling | 1.2% (2/166) | 3.67 | 0.010831 | 0.030294 |
GO:1902903 | regulation of supramolecular fiber organization | 2.41% (4/166) | 2.22 | 0.011032 | 0.030824 |
GO:0042752 | regulation of circadian rhythm | 2.41% (4/166) | 2.21 | 0.011404 | 0.031731 |
GO:1905634 | regulation of protein localization to chromatin | 1.2% (2/166) | 3.63 | 0.011401 | 0.031754 |
GO:0001726 | ruffle | 1.2% (2/166) | 3.63 | 0.011401 | 0.031754 |
GO:0055092 | sterol homeostasis | 1.2% (2/166) | 3.63 | 0.011401 | 0.031754 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 3.01% (5/166) | 1.9 | 0.011512 | 0.031963 |
GO:0009792 | embryo development ending in birth or egg hatching | 3.01% (5/166) | 1.9 | 0.011512 | 0.031963 |
GO:0032868 | response to insulin | 1.81% (3/166) | 2.68 | 0.011651 | 0.032315 |
GO:0002252 | immune effector process | 2.41% (4/166) | 2.19 | 0.011785 | 0.032653 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.2% (2/166) | 3.59 | 0.011984 | 0.033168 |
GO:0032137 | guanine/thymine mispair binding | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0032142 | single guanine insertion binding | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0030263 | apoptotic chromosome condensation | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0051306 | mitotic sister chromatid separation | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0030993 | axonemal heterotrimeric kinesin-II complex | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0032197 | transposition, RNA-mediated | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0060867 | fruit abscission | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0051547 | regulation of keratinocyte migration | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0070058 | tRNA gene clustering | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0070550 | rDNA chromatin condensation | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0090232 | positive regulation of spindle checkpoint | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0008622 | epsilon DNA polymerase complex | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0033129 | obsolete positive regulation of histone phosphorylation | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0031134 | sister chromatid biorientation | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0045144 | meiotic sister chromatid segregation | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0035845 | photoreceptor cell outer segment organization | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0010695 | regulation of mitotic spindle pole body separation | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0010697 | negative regulation of mitotic spindle pole body separation | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0120150 | regulation of mitotic actomyosin contractile ring disassembly | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0120151 | positive regulation of mitotic actomyosin contractile ring disassembly | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0032139 | dinucleotide insertion or deletion binding | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0044849 | estrous cycle | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:1902990 | mitotic telomere maintenance via semi-conservative replication | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:1902969 | mitotic DNA replication | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0000742 | karyogamy involved in conjugation with cellular fusion | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0000743 | nuclear migration involved in conjugation with cellular fusion | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0071989 | establishment of protein localization to spindle pole body | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0072765 | centromere localization | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0098653 | centromere clustering | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:1990571 | meiotic centromere clustering | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:1990852 | protein transport along microtubule to spindle pole body | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:1990976 | protein transport along microtubule to mitotic spindle pole body | 0.6% (1/166) | 6.29 | 0.012687 | 0.03367 |
GO:0009653 | anatomical structure morphogenesis | 14.46% (24/166) | 0.7 | 0.012322 | 0.034069 |
GO:0022411 | cellular component disassembly | 3.01% (5/166) | 1.86 | 0.012866 | 0.034112 |
GO:0002821 | positive regulation of adaptive immune response | 1.2% (2/166) | 3.56 | 0.01258 | 0.034565 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.2% (2/166) | 3.56 | 0.01258 | 0.034565 |
GO:0019953 | sexual reproduction | 1.2% (2/166) | 3.56 | 0.01258 | 0.034565 |
GO:1902107 | positive regulation of leukocyte differentiation | 1.2% (2/166) | 3.56 | 0.01258 | 0.034565 |
GO:1903708 | positive regulation of hemopoiesis | 1.2% (2/166) | 3.56 | 0.01258 | 0.034565 |
GO:0007009 | plasma membrane organization | 1.2% (2/166) | 3.56 | 0.01258 | 0.034565 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 1.2% (2/166) | 3.52 | 0.013188 | 0.034722 |
GO:0090436 | leaf pavement cell development | 1.2% (2/166) | 3.52 | 0.013188 | 0.034722 |
GO:0045619 | regulation of lymphocyte differentiation | 1.2% (2/166) | 3.52 | 0.013188 | 0.034722 |
GO:0048565 | digestive tract development | 1.2% (2/166) | 3.52 | 0.013188 | 0.034722 |
GO:0006907 | pinocytosis | 1.2% (2/166) | 3.52 | 0.013188 | 0.034722 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 1.2% (2/166) | 3.52 | 0.013188 | 0.034722 |
GO:0000792 | heterochromatin | 1.81% (3/166) | 2.62 | 0.013126 | 0.034767 |
GO:0032879 | regulation of localization | 9.04% (15/166) | 0.91 | 0.014037 | 0.036921 |
GO:0009059 | macromolecule biosynthetic process | 7.83% (13/166) | 1.0 | 0.014174 | 0.037244 |
GO:0045121 | membrane raft | 1.81% (3/166) | 2.57 | 0.01438 | 0.037747 |
GO:0007268 | chemical synaptic transmission | 1.2% (2/166) | 3.45 | 0.014443 | 0.037763 |
GO:0098916 | anterograde trans-synaptic signaling | 1.2% (2/166) | 3.45 | 0.014443 | 0.037763 |
GO:0008353 | RNA polymerase II CTD heptapeptide repeat kinase activity | 1.2% (2/166) | 3.45 | 0.014443 | 0.037763 |
GO:0030183 | B cell differentiation | 1.2% (2/166) | 3.45 | 0.014443 | 0.037763 |
GO:0098857 | membrane microdomain | 1.81% (3/166) | 2.56 | 0.014704 | 0.038406 |
GO:0031056 | regulation of histone modification | 3.01% (5/166) | 1.8 | 0.014834 | 0.03871 |
GO:0032502 | developmental process | 34.94% (58/166) | 0.37 | 0.014897 | 0.038835 |
GO:0002706 | regulation of lymphocyte mediated immunity | 1.2% (2/166) | 3.42 | 0.015089 | 0.039066 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.2% (2/166) | 3.42 | 0.015089 | 0.039066 |
GO:0031514 | motile cilium | 1.2% (2/166) | 3.42 | 0.015089 | 0.039066 |
GO:0051653 | spindle localization | 1.2% (2/166) | 3.42 | 0.015089 | 0.039066 |
GO:0007131 | reciprocal meiotic recombination | 1.2% (2/166) | 3.42 | 0.015089 | 0.039066 |
GO:0140527 | reciprocal homologous recombination | 1.2% (2/166) | 3.42 | 0.015089 | 0.039066 |
GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 1.2% (2/166) | 3.42 | 0.015089 | 0.039066 |
GO:0031175 | neuron projection development | 1.81% (3/166) | 2.53 | 0.015363 | 0.039698 |
GO:0010091 | trichome branching | 2.41% (4/166) | 2.08 | 0.015354 | 0.039712 |
GO:0002819 | regulation of adaptive immune response | 1.2% (2/166) | 3.39 | 0.015747 | 0.040493 |
GO:0099536 | synaptic signaling | 1.2% (2/166) | 3.39 | 0.015747 | 0.040493 |
GO:0099537 | trans-synaptic signaling | 1.2% (2/166) | 3.39 | 0.015747 | 0.040493 |
GO:0003925 | G protein activity | 1.2% (2/166) | 3.39 | 0.015747 | 0.040493 |
GO:0010883 | regulation of lipid storage | 1.2% (2/166) | 3.39 | 0.015747 | 0.040493 |
GO:0006810 | transport | 16.87% (28/166) | 0.6 | 0.015998 | 0.041097 |
GO:0032138 | single base insertion or deletion binding | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0071107 | response to parathyroid hormone | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0008278 | cohesin complex | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0010213 | non-photoreactive DNA repair | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0031272 | regulation of pseudopodium assembly | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0060718 | chorionic trophoblast cell differentiation | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0070365 | hepatocyte differentiation | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0071532 | ankyrin repeat binding | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0000700 | mismatch base pair DNA N-glycosylase activity | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0035404 | obsolete histone-serine phosphorylation | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0021952 | central nervous system projection neuron axonogenesis | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0001951 | intestinal D-glucose absorption | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0010737 | protein kinase A signaling | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0022617 | extracellular matrix disassembly | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0030046 | parallel actin filament bundle assembly | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0032532 | regulation of microvillus length | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0032536 | regulation of cell projection size | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0051639 | actin filament network formation | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0060088 | auditory receptor cell stereocilium organization | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0060121 | vestibular receptor cell stereocilium organization | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0070649 | formin-nucleated actin cable assembly | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0071801 | regulation of podosome assembly | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0071803 | positive regulation of podosome assembly | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0098699 | structural constituent of presynaptic actin cytoskeleton | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0099079 | actin body | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0099181 | structural constituent of presynapse | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0106001 | intestinal hexose absorption | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0110009 | formin-nucleated actin cable organization | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0120106 | mitotic actomyosin contractile ring, distal actin filament layer | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:1902404 | mitotic actomyosin contractile ring contraction | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:1902896 | terminal web assembly | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:1904529 | regulation of actin filament binding | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:1904530 | negative regulation of actin filament binding | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:1904616 | regulation of actin binding | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:1904617 | negative regulation of actin binding | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:1990357 | terminal web | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0007053 | spindle assembly involved in male meiosis | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0009971 | anastral spindle assembly involved in male meiosis | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0055048 | anastral spindle assembly | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 0.6% (1/166) | 5.88 | 0.01688 | 0.041665 |
GO:0007275 | multicellular organism development | 11.45% (19/166) | 0.76 | 0.016904 | 0.041684 |
GO:0009410 | response to xenobiotic stimulus | 1.2% (2/166) | 3.32 | 0.0171 | 0.041779 |
GO:0001835 | blastocyst hatching | 1.2% (2/166) | 3.32 | 0.0171 | 0.041779 |
GO:0035188 | hatching | 1.2% (2/166) | 3.32 | 0.0171 | 0.041779 |
GO:0071684 | organism emergence from protective structure | 1.2% (2/166) | 3.32 | 0.0171 | 0.041779 |
GO:0050870 | positive regulation of T cell activation | 1.2% (2/166) | 3.32 | 0.0171 | 0.041779 |
GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 1.2% (2/166) | 3.32 | 0.0171 | 0.041779 |
GO:0034097 | response to cytokine | 3.01% (5/166) | 1.75 | 0.016995 | 0.04187 |
GO:0032388 | positive regulation of intracellular transport | 1.81% (3/166) | 2.48 | 0.017084 | 0.041973 |
GO:0050807 | regulation of synapse organization | 1.81% (3/166) | 2.48 | 0.017084 | 0.041973 |
GO:1905475 | regulation of protein localization to membrane | 1.81% (3/166) | 2.48 | 0.017084 | 0.041973 |
GO:0030182 | neuron differentiation | 1.81% (3/166) | 2.5 | 0.016384 | 0.042047 |
GO:0043112 | receptor metabolic process | 1.2% (2/166) | 3.36 | 0.016418 | 0.042094 |
GO:0010556 | regulation of macromolecule biosynthetic process | 16.27% (27/166) | 0.61 | 0.017264 | 0.042142 |
GO:2000243 | positive regulation of reproductive process | 3.61% (6/166) | 1.55 | 0.017379 | 0.042383 |
GO:0007399 | nervous system development | 1.81% (3/166) | 2.46 | 0.017441 | 0.042495 |
GO:0048229 | gametophyte development | 6.02% (10/166) | 1.12 | 0.017735 | 0.04317 |
GO:0010216 | maintenance of DNA methylation | 1.2% (2/166) | 3.29 | 0.017795 | 0.043197 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 1.2% (2/166) | 3.29 | 0.017795 | 0.043197 |
GO:1902117 | positive regulation of organelle assembly | 1.2% (2/166) | 3.29 | 0.017795 | 0.043197 |
GO:0010605 | negative regulation of macromolecule metabolic process | 12.05% (20/166) | 0.73 | 0.018159 | 0.044041 |
GO:0015030 | Cajal body | 1.2% (2/166) | 3.26 | 0.018501 | 0.044829 |
GO:2000241 | regulation of reproductive process | 8.43% (14/166) | 0.9 | 0.019144 | 0.046345 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 1.2% (2/166) | 3.24 | 0.019218 | 0.046398 |
GO:0009952 | anterior/posterior pattern specification | 1.2% (2/166) | 3.24 | 0.019218 | 0.046398 |
GO:0022409 | positive regulation of cell-cell adhesion | 1.2% (2/166) | 3.24 | 0.019218 | 0.046398 |
GO:0001934 | positive regulation of protein phosphorylation | 2.41% (4/166) | 1.98 | 0.019274 | 0.04649 |
GO:0051253 | negative regulation of RNA metabolic process | 7.23% (12/166) | 0.98 | 0.019595 | 0.047222 |
GO:0048812 | neuron projection morphogenesis | 1.81% (3/166) | 2.4 | 0.019668 | 0.047311 |
GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 1.81% (3/166) | 2.4 | 0.019668 | 0.047311 |
GO:0007265 | Ras protein signal transduction | 1.2% (2/166) | 3.21 | 0.019948 | 0.047853 |
GO:0006942 | regulation of striated muscle contraction | 1.2% (2/166) | 3.21 | 0.019948 | 0.047853 |
GO:0055117 | regulation of cardiac muscle contraction | 1.2% (2/166) | 3.21 | 0.019948 | 0.047853 |
GO:0050877 | nervous system process | 3.01% (5/166) | 1.69 | 0.019977 | 0.04788 |
GO:0048858 | cell projection morphogenesis | 1.81% (3/166) | 2.38 | 0.020444 | 0.04891 |
GO:0120039 | plasma membrane bounded cell projection morphogenesis | 1.81% (3/166) | 2.38 | 0.020444 | 0.04891 |
GO:0021702 | cerebellar Purkinje cell differentiation | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0140463 | chromatin-protein adaptor activity | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0036292 | DNA rewinding | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0071140 | resolution of mitotic recombination intermediates | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0043326 | chemotaxis to folate | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0043988 | obsolete histone H3-S28 phosphorylation | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0051893 | regulation of focal adhesion assembly | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0090109 | regulation of cell-substrate junction assembly | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0016938 | kinesin I complex | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0061673 | mitotic spindle astral microtubule | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0070199 | establishment of protein localization to chromosome | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0070462 | plus-end specific microtubule depolymerization | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0071163 | DNA replication preinitiation complex assembly | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0006287 | base-excision repair, gap-filling | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0001966 | thigmotaxis | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0021542 | dentate gyrus development | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0098693 | regulation of synaptic vesicle cycle | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0033186 | CAF-1 complex | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0031422 | RecQ family helicase-topoisomerase III complex | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0036449 | microtubule minus-end | 0.6% (1/166) | 5.56 | 0.021056 | 0.049304 |
GO:0036064 | ciliary basal body | 1.2% (2/166) | 3.18 | 0.020689 | 0.049362 |
GO:1903037 | regulation of leukocyte cell-cell adhesion | 1.2% (2/166) | 3.18 | 0.020689 | 0.049362 |
GO:0055038 | recycling endosome membrane | 1.2% (2/166) | 3.18 | 0.020689 | 0.049362 |
GO:0031324 | negative regulation of cellular metabolic process | 10.24% (17/166) | 0.78 | 0.020845 | 0.049689 |